02

docx

School

Kenyatta University *

*We aren’t endorsed by this school

Course

3500

Subject

Management

Date

Nov 24, 2024

Type

docx

Pages

58

Uploaded by Amathu

Report
ORGANIZATIONAL ANALYSIS OF J&J Table of Contents Table of Contents ......................................................................................................................................... 2 Executive Summary ..................................................................................................................................... 4 Organizational Overview ............................................................................................................................. 5 Organizational Strategy ............................................................................................................................... 7 Mission, Vission, and Values .................................................................................................................... 7 Miles and Snow Typology ........................................................................................................................ 8 1
ORGANIZATIONAL ANALYSIS OF J&J Porter's Competitive Strategies ............................................................................................................. 10 Goals and Objectives ............................................................................................................................. 11 Organizational Structure, Design, and Effectiveness .................................................................................. 12 External Environment ................................................................................................................................ 15 Industry Sector ...................................................................................................................................... 15 Raw Materials Sector ............................................................................................................................ 16 Human Resources Sector ....................................................................................................................... 17 Financial Resources Sector .................................................................................................................... 18 Market Sector ........................................................................................................................................ 19 Technology Sector ................................................................................................................................. 20 Economic Sector .................................................................................................................................... 21 Government Sector ............................................................................................................................... 22 Sociocultural Sector ............................................................................................................................... 23 International Sector ............................................................................................................................... 24 Internal Environment ................................................................................................................................. 25 Management ......................................................................................................................................... 25 Marketing .............................................................................................................................................. 27 Production/Operation ........................................................................................................................... 28 Finance/Accounting ............................................................................................................................... 29 Research & Development ...................................................................................................................... 31 Organizational Design for an International Environment ........................................................................... 34 Products and Services ................................................................................................................................ 36 Information Technology & Control Systems ............................................................................................... 38 Organizational Size, Life Cycle, and Possible Decline ................................................................................. 41 Organization Size ................................................................................................................................... 41 Life Cycle ............................................................................................................................................... 42 Entrepreneurial stage ........................................................................................................................ 42 Collectivity stage ............................................................................................................................... 42 2
ORGANIZATIONAL ANALYSIS OF J&J Formalization stage ........................................................................................................................... 43 Elaboration stage .............................................................................................................................. 43 Possible Decline ..................................................................................................................................... 44 Organizational Culture ............................................................................................................................... 45 Ethical Values ............................................................................................................................................. 47 Innovation and Change .............................................................................................................................. 48 Innovation ............................................................................................................................................. 48 Change .................................................................................................................................................. 50 Decision-Making ........................................................................................................................................ 49 Conflict, Power, and Politics ....................................................................................................................... 52 Conflict .................................................................................................................................................. 52 Power and Politics ................................................................................................................................. 53 Key Findings and Recommendations ......................................................................................................... 54 Key Findings .......................................................................................................................................... 54 Recommendations ................................................................................................................................ 55 Bibliography ............................................................................................................................................. 56 Executive Summary Johnson & Johnson (J&J) has been an established entity in the healthcare sector since its founding in 1886. 1 With an importance surpassing its impressive financial performance in 2021, with over $93 billion in revenue and a global workforce of more than 136,000 individuals. 2 The organization has made significant contributions in various areas, including pioneering advancements in the medical field and developing drugs that have saved lives. 3 Additionally, 1 Drugdangers. (2023). Johnson & Johnson. Retrieved from https://www.drugdangers.com/manufacturers/johnson-and- johnson/#:~:text=The%20company%20was%20founded%20in,to%20the%20logo%20used%20today/ 2 Johnson & Johnson( 2023, Aug 31) Johnson & Johnson - Statistics & Facts. Retrieved from https://www.statista.com/topics/1517/johnson-and-johnson/ 3 Johnson & Johnson. (2023). Johnson & Johnson -About us. Retrieved from: https://www.jnjcanada.com/about-us 3
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J they have also produced consumer items that improve the overall health and well-being of a large number of individuals. In addition to its financial endeavors, J&J's significant influence stems from its dedication to a guiding principle that prioritizes the welfare of patients, healthcare professionals, employees, communities, and shareholders as fundamental values. This ethos has firmly established the company's standing as a prominent ethical authority within a sector that holds significant importance for the well-being of humanity. This extensive examination is inspired by a primary objective: to explore the numerous facets of Johnson & Johnson. The aim is to thoroughly examine the organization's structural complexities, operational intricacy, adaptation to external factors, internal dynamics, decision- making mechanisms, and conflict resolution procedures. Through this process, the analysis aims to uncover both the positive aspects and obstacles that characterize J&J's present position and to reveal strategic suggestions that can accurately guide its future trajectory. This research is an intellectual endeavor and a pragmatic resource to guide the company's trajectory in a swiftly changing healthcare environment. Johnson & Johnson's expansive worldwide presence and strategic expansion into the pharmaceuticals, medical devices, and consumer health sectors are the foundation for its operational durability. 4 Implementing this diversification approach has facilitated J&J in effectively navigating market volatility and sustaining a robust global market presence. The commitment demonstrated by the company leads to the development of a strong and advanced portfolio of healthcare goods and therapies, thereby solidifying its standing as a leader in the field. Johnson & Johnson's decentralized organizational structure grants autonomy to local entities, allowing the corporation to cater to various healthcare requirements in various geographical areas effectively. J&J's utilization of data analysis in supply chain management and crisis response highlights the company's adeptness in making data-based decisions. Johnson & Johnson demonstrates exceptional resilience in navigating internal and external issues effectively. 5 The resilience demonstrated by the organization is strengthened by its dedication to fostering open communication and an unwavering will to achieve settlements that are advantageous to all parties involved. As a result, J&J has emerged as a prominent figure in conflict management within the healthcare sector. Johnson & Johnson should prioritize the integration of advanced data analysis and implementing emerging technologies such as artificial intelligence (AI) and the Internet of Things (IoT). An increased emphasis on sustainable practices and strengthening corporate social responsibility activities can augment J&J's public perception as a responsible corporate organization. In light of the inherent instability observed in the global market, J&J should prioritize enhancing its supply chain resilience and diversification efforts. It is paramount to 4 Johnson & Johnson our history.(2023). Reveived from: https://ourstory.jnj.com/our-beginning#experience-our-beginning-ch-1- 3 5 Johnson & Johnson our history.(2023). Reveived from: https://ourstory.jnj.com/our-beginning#experience-our- beginning-ch-1-3 4
ORGANIZATIONAL ANALYSIS OF J&J actively engage with regulatory authorities and consistently comply with new standards to navigate the intricate healthcare regulatory environment effectively. Recent global health crises have underscored the significance of crisis management and response techniques. Johnson & Johnson (J&J) should emphasize improving its crisis preparedness procedures to effectively respond to unexpected difficulties, thereby protecting its operations and image. Organizational Overview Johnson & Johnson (J&J) was established in 1886 and emerged as a tangible manifestation of a visionary idea. The company was founded by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, who identified a potential to transform the provision of medical services within the healthcare industry. The organization was established during a period characterized by a high prevalence of post-surgical infections, frequently resulting in fatalities due to unsterile settings. Johnson & Johnson proposed a pioneering concept involving the utilization of sterile surgical coverings to address the challenges eminent in the healthcare sector. This undertaking transcended commercial interests since it aimed to address a substantial health issue. This unique methodology addressed an existing market gap, facilitated the implementation of more secure surgical techniques, and preserved numerous lives. With time, Johnson & Johnson broadened its scope by expanding its portfolio of products and venturing into domains previously unexplored by other healthcare providers. The ability to adapt was a fundamental factor that contributed to the sustained expansion of J&J. Since the 1890s, J&J has demonstrated a persistent ability to foresee medical needs and offer new solutions, such as the creation of first aid kits, pioneering dental floss, and developing maternity kits to enhance the safety of childbirth. 6 During the 20th century, Johnson & Johnson successfully established and strengthened its presence on a global scale. The company expanded its operations into the pharmaceutical industry, leveraging advancements in technology and research approaches to develop and manufacture critical medications and cures with the potential to save lives. The company's dedication to tackling global health issues positioned it as a leader amid numerous health emergencies. For instance, the company was crucial in combating tuberculosis in the early 1900s. It also contributed to the manufacturing of vital medications during World War II. J&J has seen a remarkable evolution from its humble beginnings in a tiny hamlet, emerging as a prominent global force in the healthcare industry. The trajectory of its progression, marked by a multitude of groundbreaking advancements, strategic acquisitions, and pioneering problem- solving approaches, exemplifies a longstanding commitment to improving human health. Johnson & Johnson (J&J) emerges as a substantial enterprise, distinguished by its considerable magnitude and diverse involvement in health across multiple domains. The 6 Patel, Rikin, Mohamad Kaki, Venkat S. Potluri, Payal Kahar, and Deepesh Khanna. (2022, Dec 21). "A comprehensive review of SARS-CoV-2 vaccines: Pfizer, moderna & Johnson & Johnson." Human Vaccines & Immunotherapeutics. 5
ORGANIZATIONAL ANALYSIS OF J&J Pharmaceuticals division plays a crucial role in supporting the company's purpose. Johnson & Johnson (J&J) has consistently demonstrated a strong dedication to advancing medical research and fostering innovation. The pharmaceutical division is deeply committed to drug development, including scientific exploration, rigorous testing, and distribution. This dedication is firmly grounded in the quest for scientific discovery. The significance of J&J's achievements in oncology, immunology, neuroscience, and infectious illnesses has greatly attracted the healthcare sector. J&J demonstrates its commitment to addressing and overcoming global health concerns by providing various pharmaceutical goods, including prescription medications and vaccines. This dedication is driven by the company's aspiration to establish a world where excellent health is not a privilege but a standard expectation. The Medical Devices segment manifests J&J's acknowledgment that healthcare includes more than just pharmaceuticals. The achievement of optimal therapeutic outcomes frequently requires the utilization of specialist equipment and gear. This portion functions as a pivotal point where advanced engineering intersects with the field of medical science. The company's commitment lies in equipping healthcare professionals with top- quality tools to protect and restore health. The Consumer Well-being segment is the most prominent aspect of J&J in terms of public visibility. This division functions at the convergence of medical knowledge and the realm of everyday existence, guaranteeing the availability of health and well-being to all individuals. Johnson & Johnson (J&J) impacts the lives of numerous individuals daily through its extensive assortment of over-the-counter (OTC) merchandise. 7 Historically, Johnson's Baby has garnered the trust of numerous generations of parents, Neutrogena has established itself as a symbol of skin health, Tylenol has become a preferred choice for alleviating pain, and Band-Aid is frequently employed as an initial measure in addressing small injuries. These brands and products exemplify J&J's dedication to promoting wellness in daily life, hence emphasizing the importance of accessible healthcare within medical facilities. Johnson & Johnson's financial performance has continuously demonstrated outstanding growth. The company's annual revenues reached an impressive $82 billion as of 2021, showing its significant global standing and strong brand equity. The impressive financial performance of J&J, with net earnings amounting to almost $15 billion, can be due to several key factors. 8 These include the company's diverse brand portfolio, extensive global presence, and steadfast dedication to research and innovation. J&J has strategically established its global operations by situating its core headquarters in New Brunswick, New Jersey. A complex network of regional offices, research centers, subsidiaries, and global partners reinforces the foundation of New Jersey's operations. The worldwide distribution of J&J's products aids the company's ability to enter new markets and allows for effective adaptation and response to various market dynamics and regulatory frameworks. Johnson & Johnson is a prominent entity in the healthcare industry 7 Bocken, Nancy MP, and Thijs HJ Geradts. (2022)."Barriers and drivers to sustainable business model innovation: Organization design and dynamic capabilities. 8 Lindsley, Craig W. (2018). "New 2017 data and statistics for pharmaceutical products." ACS Chemical Neuroscience. 6
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J that greatly values its extensive pool of skilled personnel. The firm exhibits a prominent presence, with a substantial workforce of over 136,000 employees globally. The workforce of J&J is distributed throughout many functional areas, such as research and development, manufacturing, sales, marketing, and administration. This broad composition of employees shows J&J's inclusive and extensive operational activities. Organizational Strategy Mission, Vision, and Values An organization's mission, vision, and values are integral components that define its identity. These elements offer guidance and are the foundation for the underlying principles influencing every organizational decision. The mission statement often delineates the company's underlying goals. In contrast, the vision statement delineates the organization's future state as a strategic guide. Organizational values are fundamental principles that guide conduct and ensure that actions align with a well-defined moral and ethical framework. Johnson & Johnson's mission statement illustrates a testament to its enduring commitment to the healthcare sector. The mission states, "Bringing science and sense of sight to life through world-class innovation and customer experience." 9 This mission surpasses simple verbal expressions, exemplifying the company's commitment to effecting profound changes in the lives of countless individuals. Johnson & Johnson's (J&J) efforts to enhance the quality of life for consumers by offering an extensive array of items, from baby and oral care to innovative medical gadgets utilized in orthopedics and surgery. The emphasis on health and well-being highlights the company's sincere aspiration to lead health-oriented innovation, dedicating significant efforts, expertise, and resources to improving health outcomes. Johnson & Johnson's vision statement is; "To help people see better, connect better, live better," is an articulate reflection of its comprehensive aspiration for humanity. 10 The vision is imbued with significance that encapsulates the organization's perspective on health and wellness. The phrase "To help people see better" illustrates the promotion of ocular health and symbolizes the company's dedication to enhancing the quality of life, expanding knowledge and perspectives, and assisting individuals in identifying prospects and capabilities. This statement signifies a commitment to overcoming obstacles and eliminating obstacles obstructing clear perception, whether through medical interventions or the diverse range of products and solutions it provides. 11 The expression "enhance interpersonal connections" explores well-being's emotional and psychological dimensions. Johnson & Johnson (J&J) prioritizes promoting 9 Business Strategy Hub. (2023). Johnson & Johnson Mission Statement| Vision| Core Values| Analysis 2023. Retrieved from: https://bstrategyhub.com/johnson-johnson-mission-statement-vision-core-values-analysis/ 10 Johnson & Johnson MedTech. (n.d.) Retrived from: https://www.jjvision.com/about-us 11 Lindsley, Craig W. (2018). "New 2017 data and statistics for pharmaceutical products." ACS Chemical Neuroscience. 7
ORGANIZATIONAL ANALYSIS OF J&J physical well-being and cultivating emotional connections, comprehension, and empathy. This approach aims to facilitate stronger social cohesion and improve mutual understanding among individuals. Additionally, the phrase "live better" effectively encapsulates the comprehensive nature of J&J's overarching purpose. This statement is a comprehensive appeal to enhance the general living standard, enabling each person to experience a satisfying existence. This aspect of the organization's vision acknowledges that life extends beyond survival or the absence of illness. It encompasses flourishing, experiencing happiness, and attaining a sense of meaning and satisfaction. At the foundation of Johnson & Johnson's corporate philosophy lies its Credo, a collection of core values that offer guidance and meaning to all undertakings carried out by the company. The values that stand out are "Giving" and "Sustainability." The Johnson & Johnson Corporate Contributions Report emphasizes several activities that exemplify the importance of philanthropy. These efforts aim to enhance and preserve the well-being of individuals, particularly women, and children, by strengthening the healthcare workforce and mitigating diseases within marginalized communities. In contrast, "Sustainability" exemplifies J&J's overarching dedication to the environment and society. The company's efforts in resource conservation, addressing global healthcare concerns, and undertaking socially beneficial business activities demonstrate its dedication to promoting a more sustainable and healthier future. These core values are the foundation for the company's business goals and highlight its broader responsibility as a global corporate entity. Miles and Snow Typology The Miles and Snow typology is a widely recognized strategic framework that classifies firms into four distinct categories according to their reactions to changes in the external environment and their approaches to innovation. The classification includes the categories of Prospector, Defender, Analyzer, and Reactor, providing valuable insights into organizations' strategic orientation and accompanying behaviors within competitive markets. Prospectors exhibit a proactive approach in actively searching for novel business prospects. These organizations serve as pioneers, consistently embarking on ventures in unfamiliar domains, launching novel products, and investigating inventive market sectors. 12 In contrast, defenders are entities who diligently protect their established market territories. The company significantly emphasizes optimizing operational efficiency and maintains a strategic approach that prioritizes staying within the boundaries of its core business activities. Analyzers achieve a balanced ground by incorporating elements from the techniques utilized by Prospectors and Defenders. The organization maintains a secure foundation of well-established activities while carefully pursuing new market opportunities. This dual approach provides Analyzer organizations with the benefit of stability derived from their core operations and the possibility for expansion through new 12 Abubakar, Abubakar Mohammed, Hamzah Elrehail, Maher Ahmad Alatailat, and Alev Elçi. (2015). "Knowledge management, decision-making style and organizational performance." Journal of Innovation & Knowledge. 8
ORGANIZATIONAL ANALYSIS OF J&J business ventures. Reactors are characterized by a lack of cohesive strategic positioning, frequently leading to short-term and inconsistent decision-making in reaction to shifts in the external environment. Johnson & Johnson can be categorized as an Analyzer in the healthcare industry. This connection arises from Johnson & Johnson's proficiency in integrating innovation with stability. This strategic approach guarantees that Johnson & Johnson maintains its relevance and remains a trailblazing entity within the ever-evolving healthcare sector. The historical background and strategic approach of Johnson & Johnson closely correspond to the attributes associated with the Analyzer archetype, as outlined in the Miles and Snow typology. The corporation has consistently upheld its primary business lines while expanding into novel enterprises. The company's initial dedication to manufacturing aseptic surgical dressings laid the groundwork for its subsequent diversification into pharmaceuticals, medical equipment, and consumer health goods. This demonstrates the company's adeptness in maintaining the stability of established markets while simultaneously venturing into novel investments. In 2020, Johnson & Johnson made a substantial investment of around $12.2 billion in research and development (R&D). 13 The substantial investment suggests the corporation is committed to safeguarding its established market position while also being enthusiastic about pursuing new prospects, which aligns with the characteristics of the Analyzer typology. Additionally, the implementation of a diversified portfolio across many healthcare sectors by Johnson & Johnson exemplifies the operationalization of its Analyzer characteristics. While the company maintains certain product lines that generate consistent revenue, other segments demonstrate their ability to adapt and explore new opportunities, particularly the innovative results of their research and development efforts. The capacity to encompass a wide range of activities enables them to serve a larger clientele effectively and offers protection against market volatility in the industries. The company's agility and adaptability are also seen in its ability to address market problems effectively. An exemplary illustration is demonstrated in the company's expeditious progress and implementation of the COVID-19 vaccine. While effectively maintaining their existing business operations, they skillfully addressed a global health problem, demonstrating a characteristic trait of analytical thinking by simultaneously preserving core operations and implementing innovative measures in reaction to external factors. The company customizes its products and services to cater to the specific characteristics and preferences of the local market. The amalgamation of worldwide influence alongside localized customization aligns with the well-balanced methodology of an Analyzer, integrating regular procedures with adaptable tactics. Johnson & Johnson's steadfast dedication to sustainability and corporate responsibility is a testament to the company's enduring strategic foresight. Johnson & Johnson's emphasis on establishing a sustainable environment and promoting a healthier future exemplifies their inclination towards analytical decision-making. 13 Xie, Zhongjian, Taojian Fan, Jusung An, Wonseok Choi, Yanhong Duo, Yanqi Ge, Bin Zhang et al. (2022). "Emerging combination strategies with phototherapy in cancer nanomedicine." Chemical Society Reviews 49. 9
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Porter's Competitive Strategies In his seminal work, Michael Porter formulated Porter's Competitive Strategies Model, which delineates organizations' major tactics to achieve and preserve competitive advantage in their respective industries. This conceptual framework classifies organizational strategies into three overarching principles: Cost Leadership, which entails businesses striving to achieve the status of the most economical producer within their industry; Differentiation, which involves companies aiming to provide products or services that are unique and superior to those offered by their competitors; and Focus, which refers to organizations directing their efforts towards serving a specific segment or niche of the market more efficiently than their rivals. Within the vast and diverse domain of the global healthcare sector, Johnson & Johnson's strategic approach exemplifies a well-balanced integration of Porter's Differentiation and Focus strategies. 14 The ability of Johnson & Johnson to differentiate itself within the very competitive healthcare industry is praiseworthy. The differentiation manifests in the extensive range of healthcare products' originality, innovation, and exceptional quality. The company's strong brand equity serves as additional evidence of the effectiveness of its differentiation strategy. The brands within the J&J conglomerate, like Neutrogena and Tylenol, have achieved widespread recognition and are widely known for their high-quality standards, dependability, and exceptional performance. In addition to its differentiation strategy, Johnson & Johnson effectively utilizes a Focus strategy by targeting certain areas within the large healthcare market. Instead of pursuing a universal approach, J&J customizes its products and services to effectively address the distinct and specific requirements of its broad customer base, which includes healthcare experts, patients, and general consumers. Johnson & Johnson's strategic emphasis on specific therapeutic areas within the pharmaceutical business illustrates this concentrated approach. Johnson & Johnson has strategically allocated its resources and specialized knowledge to focus on particular areas of study, such as oncology and immunology. As a result, the company has engaged in these sectors and emerged as a prominent leader, setting standards in terms of treatment effectiveness and the well-being of patients. Goals and Objectives Johnson & Johnson's operating culture is centered around comprehensive organizational goals and objectives. These elements are firmly ingrained in the organization's mission, vision, and values, exemplifying its steadfast commitment to enhancing lifestyles, providing unmatched customer experiences, and revitalizing communities. The core goals of Johnson & Johnson align with its dedication to driving progress in global healthcare while maintaining strong financial performance. The organization demonstrates a strong commitment to enhancing healthcare. An essential element of the company's approach involves its dedication to developing and implementing healthcare interventions that enhance the well-being of individuals on a global 14 Johnson & Johnson. (n.d.). Johnson & Johnson: How we are organized. Retrieved from: https://www.jnj.com/sites/default/files/pdf/how- we-are-organized.pdf/ 10
ORGANIZATIONAL ANALYSIS OF J&J scale. This comprises innovative advancements in the pharmaceutical industry and cutting-edge medical gadgets that address essential medical requirements. Within a global framework, the firm demonstrates a strong commitment to tackling health concerns on a global scale. This encompasses enhancing the availability of healthcare services in marginalized groups, advocating for the well-being of mothers and children, and actively addressing the spread of infectious diseases. From a financial standpoint, Johnson & Johnson, like many other publicly traded corporations, aims to increase its revenue to enhance shareholder value constantly. The process involves product innovation, market expansion, and effective cost control. 15 Maintaining profitability and securing long-term financial stability are also fundamental objectives for the organization, necessitating efficient operating practices and prudent financial management. Incorporating sustainability and corporate responsibility is essential to Johnson & Johnson's operational framework. The organization is strongly dedicated to environmental accountability, evidenced by its goals of mitigating carbon emissions, effective waste disposal, and procuring sustainable resources. In addition to its environmental initiatives, Johnson & Johnson emphasizes corporate social responsibility. This entails the practice of ethical business conduct, cultivating a culture that values diversity and inclusion, and active participation in community engagement. In order to achieve its ambitious objectives, Johnson & Johnson has developed a range of strategic methodologies. One crucial approach is deploying resources towards research and development. By consistently allocating a substantial amount of its income towards research and development initiatives, the corporation has successfully taken the lead in developing novel medications, medical equipment, and consumer health goods that effectively cater to unfulfilled medical needs. 16 Johnson & Johnson has also gained recognition for its expertise in mergers and acquisitions. This strategy has facilitated the integration of enterprises possessing specialized knowledge, expanding their range of products, and accessing untapped markets. The company's strategic approach is exemplified by its collaborations with Actelion, specializing in pulmonary hypertension, and Synthes, a prominent player in orthopedic appliances. In order to expand its presence on a worldwide scale, the company has actively pursued opportunities in emerging regions, establishing partnerships with healthcare institutions and government agencies at the local level. Implementing this dual approach augments the company's financial inflows and strengthens its effectiveness in tackling global health issues. Johnson & Johnson has been at the forefront of implementing environmentally friendly initiatives in alignment with its sustainability and corporate responsibility objectives. This entails activities to mitigate greenhouse gas emissions, preserve water resources, and strive for a zero-waste impact in its operational activities. 15 Johnson & Johnson (n.d) Position on Ethics and Compliance. Retrieved from https://www.our-position-on-ethics- and-compliance/ 16 Johnson &Johnson.(2021). Pharmaceuticals. Retrieved from: https://www.com/healthcare- products/pharmaceuticals/ 11
ORGANIZATIONAL ANALYSIS OF J&J Organizational Structure, Design, and Effectiveness Organizations, particularly those of considerable scale and international scope, such as Johnson & Johnson, must possess a well-defined and streamlined organizational structure to achieve optimal operational efficacy. The organizational structure is the foundational framework around which a corporation constructs its strategies, operations, and cultures. As the contextual landscape in which an organization operates transforms, it is not unusual for the organizational structure to undergo modifications to achieve greater congruence with its objectives and the challenges it faces. Johnson & Johnson, like several existing conglomerates, has undergone diverse forms of organizational restructuring. During its early developmental phases, the organization adopted a rudimentary functional structure, wherein departments were structured according to specific functions such as marketing, finance, and production. The rudimentary design is characteristic of burgeoning enterprises that necessitate the establishment of operational lucidity. Considering the global expansion and product diversification undertaken by Johnson & Johnson, a matrix or divisional organizational structure is depicted to be more appropriate. This architecture facilitates the company's efficient operations across several locations and product categories. Each division operates with a certain degree of autonomy while remaining aligned with the overarching company objective. Currently, Johnson & Johnson functions as a decentralized conglomerate. This implies that although a comprehensive global strategy and brand identity exist, the subsidiary companies and business divisions maintain a certain level of independence in their operations. This is evident in its three primary business divisions: Consumer, Pharmaceutical, and Medical Devices. Each category serves specific markets, presents its issues, and demands specialized skills. Consequently, the personnel is afforded the independence to formulate and execute strategies most appropriate for their specific operational contexts while ensuring congruence with the overarching objectives and aspirations of the broader organization. 17 The extensive global presence of Johnson & Johnson underscores the need for a decentralized approach. Regional executives oversee a corporation's operational aspects within designated regions, focusing on tailoring strategies to align with each region's unique requirements and challenges. The decentralized conglomerate structure employed by Johnson & Johnson is a strategic approach that combines efficiency and flexibility, playing a crucial role in the company's overall performance. From an efficiency standpoint, the organizational structure enables individual business units to concentrate on their fundamental strengths, optimize their operations, and expedite decision-making processes without requiring significant authorization from central management. This approach results in expedited reactions to market fluctuations, enhanced synchronization with consumer demands, and heightened operational effectiveness. The structure's adaptability is apparent in its ability to empower regional and business unit leaders. 17 Bartlett, C. A., & Ghoshal, S. (1989). Managing across borders: The transnational solution. HarvardBusiness School Press. 12
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Organizations can customize their strategy, aligning with the specific characteristics of local market situations, legal frameworks, and cultural subtleties. The capacity to adapt enables Johnson & Johnson to maintain relevance in a wide range of markets and effectively adjust its strategy as needed. One possible obstacle associated with a decentralized organizational structure is the potential hazard of diminishing the company's overall brand identity. The highest level of organizational hierarchy at Johnson & Johnson is held by the Chief Executive Officer (CEO). The Chief Executive Officer (CEO) maintains direct communication channels and exercises supervisory authority over the leaders of three principal business divisions. The primary role of the Consumer Segment Head encompasses the significant responsibility of overseeing all goods that directly engage with customers. This encompasses many items, including skin care products and over-the-counter pharmaceuticals. The primary duty of this leader is to guarantee that consumer products not only conform to present market trends but also exhibit innovation for the future, all while consistently preserving Johnson & Johnson's esteemed dedication to quality and safety. The head of the Pharmaceutical Segment leads the second notable division. The field in question can be considered highly complex, as it encompasses the numerous procedures involved in developing, testing, and commercializing pharmaceuticals intended to cater to a wide range of medical requirements. This leader demonstrates a collaborative approach by effectively coordinating research teams, regulatory agencies, and marketing units to facilitate the consistent delivery of novel medical solutions to the market. The third segment, Medical Devices, is overseen by its designated Segment Head. The department is crucial in producing and distributing state-of-the-art medical devices by Johnson & Johnson, which are supplied to healthcare institutions worldwide. The leader's job is crucial in upholding the company's reputation in the medical devices sector since it encompasses several domains, such as product innovation, safety protocols, and strategic market positioning. In addition to the core segment executives, Johnson & Johnson's organizational structure includes regional chiefs responsible for governing several worldwide territories, including North America, Europe, and Asia-Pacific. 18 The organization's mandate encompasses two distinct aspects: aligning with global plans at a broad level and effectively adapting operations to address local market demands and cultural subtleties. Presented here is a simplified representation of the organizational structure of the corporation. A comprehensive chart would provide a more in- depth analysis, elucidating the extensive array of departments, subsidiaries, and units within the organization. Several subtleties may be identified within the Corporate Operations section, which oversees crucial areas such as Human Resources, Finance, and Legal problems that encompass the entirety of the firm. The Executive Committee and the Board of Directors are responsible for offering comprehensive management and strategic guidance. Figure 1 illustrates a simplified organizational chart for J&J Company. 18 J ohnson & Johnson(2023, Aug 31) Johnson & Johnson - Statistics & Facts. Retrieved from https://www.statista.com/topics/1517/johnson-and-johnson/ 13
ORGANIZATIONAL ANALYSIS OF J&J External Environment Industry Sector The healthcare industry involves a diverse range of services, products, and treatments with the primary objective of promoting and enhancing the health and welfare of populations. The components under this domain encompass hospitals, medical practitioners, long-term care facilities, diagnostic services, public health initiatives, health insurance coverage, and a diverse array of additional elements. However, within the expansive realm of this economy, three prominent sectors emerge medicines, consumer health, and medical devices. 19 The pharmaceutical industry is accountable for researching, engaging in development activities, manufacturing, and promoting medications that address various health concerns. The worldwide medicines market was estimated at around $1.2 trillion in 2019. 20 According to a survey by Grand View Research in 2019, the anticipated size of the global consumer health industry was approximately $233.4 billion. The final aspect of the industry under consideration is the medical 19 Soto, F. (2022, October 27). Johnson & Johnson: Attractive opportunity during market turmoil. Seeking Alpha . https://seekingalpha.com/article/4550014-johnson-and-johnson-attractive-opportunity-during-market-turmoil / 20 Johnson & Johnson( 2023, Aug 31) Johnson & Johnson - Statistics & Facts. Retrieved , from https://www.statista.com/topics/1517/johnson-and-johnson/ Figure 1: J&J Organizational Chart 14
ORGANIZATIONAL ANALYSIS OF J&J devices sector, which primarily concerns the development of instruments, apparatuses, and equipment specifically developed for illness diagnosis, prevention, and treatment. According to Statista, the global market for medical equipment was valued at approximately $456 billion in 2019 21 . The healthcare sector experiences ongoing transformation, primarily influenced by technological developments, demographic shifts, and new health concerns. The emergence of biotechnology and gene therapies, shown by advancements such as CRISPR, signifies a transition from disease management to potentially eradicating ailments. One significant transformation that has occurred is the growing significance of emerging markets. Johnson & Johnson (J&J), being a globally recognized healthcare corporation, boasts an extensive and diverse range of products within its three primary business divisions, establishing its position as one of the most comprehensive and expansive entities in the field of healthcare. Based on the Fortune 500 rankings, Johnson & Johnson achieved a position of 37th in the year 2020, thereby consolidating its standing as a prominent entity within the global arena. J&J consistently attains a position within the top 10 pharmaceutical corporations in sales, with a notable presence in the pharmaceuticals sector. The consumer health brands of the corporation, including Neutrogena and Tylenol, are widely recognized, and established in households. The company holds a strong position in the medical equipment sector, offering a range of goods utilized in various disciplines, such as orthopedics and vision care. According to the World Preview report by EvaluatePharma, Johnson & Johnson's pharmaceutical division was the second largest globally in 2019, generating over $42 billion in sales. The current position held by J&J in the industry is evidence of its ongoing commitment to innovation, its vast market penetration, and its established reputation for delivering high-quality products and being a trustworthy entity. The figure below illustrates the industrial position of the company. Figure 2: Industrial Overview 22 21 Johnson & Johnson( 2023, Aug 31) Johnson & Johnson - Statistics & Facts. Retrieved , from https://www.statista.com/topics/1517/johnson-and-johnson/ 22 Soto, F. (2022, October 27). Johnson & Johnson: Attractive opportunity during market turmoil. Seeking Alpha . https://seekingalpha.com/article/4550014-johnson-and-johnson-attractive-opportunity-during-market-turmoil 15
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Raw Materials Sector Johnson & Johnson operates across various healthcare industry sectors, requiring distinct raw materials. Active pharmaceutical ingredients (APIs) are essential in the pharmaceutical industry. Acetaminophen, present in Tylenol, and improvise, a crucial constituent in certain cancer medicines manufactured by J&J, serve as illustrative instances from their comprehensive roster of ingredients. In the consumer health industry, various raw materials are utilized, including chemicals and natural extracts in skincare products such as Neutrogena and the components found in its over-the-counter medications. For example, baby shampoos may contain mild cleansing agents, moisturizing agents, and preservatives, all carefully manufactured to adhere to the safety and effectiveness requirements set by Johnson & Johnson. The medical devices industry represents a distinct domain. In this context, the primary constituents frequently encompass metallic elements, polymers, ceramics, and other substances employed in fabricating medical apparatus and machinery. Surgical instruments necessitate using materials such as stainless steel or titanium due to their renowned attributes of durability and non-reactivity. The sourcing of raw materials for a multinational such as Johnson & Johnson is a complex procedure that relies on strategic alliances, large-scale procurement, and effective management of worldwide supply chains. The company's procurement practices are diversified to mitigate risks related to reliance on a singular source or geographic region, with activities spanning more than 60 nations. Pharmaceutical ingredients are frequently procured from various providers to maintain a regular supply, mitigating potential disruptions in the event of supplier-related issues. Over its existence, Johnson & Johnson (J&J) has prioritized establishing partnerships with suppliers who demonstrate a shared dedication to upholding standards of quality, sustainability, and ethical conduct. The expectations outlined in the company's Supplier Code of Conduct are elucidated, ensuring all supply chain partners comply with the most stringent standards. The expansive scope of J&J's operations makes the corporation susceptible to many supply chain hazards, encompassing geopolitical conflicts, trade barriers, natural disasters, and pandemics. In order to address these problems, Johnson & Johnson implements a comprehensive risk 16
ORGANIZATIONAL ANALYSIS OF J&J management plan. This encompasses keeping strategic reserves of vital components, utilizing sophisticated data analysis to anticipate possible interruptions, and continuously evaluating and adjusting their network of suppliers. 23 There has been an observable trend towards adopting sustainable sourcing practices in recent years. This initiative aligns with J&J's overarching dedication to environmental stewardship. Through engaging in collaborative efforts with suppliers to implement sustainable practices, the company effectively mitigates its environmental impact while simultaneously fulfilling its substantial need for raw materials. Human Resources Sector Johnson & Johnson, a prominent multinational healthcare conglomerate, is renowned for its extensive and diverse workforce on a global scale. In this diverse workforce comprising individuals from various nations, one encounters a multitude of professionals with distinct areas of expertise. These include biochemists, medical researchers contributing to the research and development (R&D) departments, and marketing experts pivotal in driving the consumer products segment. The company also emphasizes its dedication to promoting gender and ethnic diversity. The presence of diverse individuals in the workforce promotes inclusivity and enhances the company's ability to develop products and solutions better aligned with the requirements of a diverse global customer base. In the highly competitive healthcare sector, acquiring high-caliber talent holds significant importance, and Johnson & Johnson is no exception in its endeavor to attract the most exceptional and talented individuals. The company's holistic recruitment strategy seeks young graduates and seasoned employees. Campus recruitment initiatives maintain a consistent flow of young and innovative individuals, while targeted headhunting and industry outreach efforts facilitate the acquisition of specialized expertise. Upon joining the organization, Johnson & Johnson demonstrated a significant commitment to enhancing its workforce through substantial investments in employee development. J&J acknowledges the correlation between the development of its workforce and its organizational growth, thus providing an extensive array of training initiatives, workshops, and avenues for pursuing advanced education. These initiatives not only facilitate the refinement of employees' existing skills but also provide them with additional competencies, preparing them for more significant responsibilities within the organization. Retention encompasses more than just the acquisition of skills. A strong and comprehensive employee value proposition is central to Johnson & Johnson's retention strategy. The company's competitive compensation packages, comprehensive health and wellness benefits, and well-defined career progression opportunities render it a highly appealing destination for individuals seeking long-term employment. In addition, the strong dedication of Johnson & Johnson to corporate social responsibility and community service is highly attractive to a significant number of employees, cultivating a profound sense of pride and a clear sense of purpose in their respective positions. The organization acknowledges the significance of upholding a harmonious equilibrium between 23 Daft, R. L. (2015). Organization theory and design. Cengage learning. 17
ORGANIZATIONAL ANALYSIS OF J&J professional and personal life. 24 J&J has implemented various measures, such as flexible working hours, remote work policies, and generous parental leave, to facilitate its employees' effective management of professional and personal commitments. The fundamental principle underlying Johnson & Johnson's human resources strategy revolves around fostering a mutually beneficial and interdependent connection with its workforce. By providing growth opportunities and establishing a supportive work environment, the company effectively ensures its sustained growth and attainment of a prominent position within the industry. Financial Resources Sector Within the ever-evolving realm of global healthcare, the continuing resilience and astute financial management of Johnson & Johnson serve as a noteworthy tribute to its financial endurance. The firm has consistently demonstrated its capacity to satisfy its short-term financial obligations by maintaining a current ratio above the industry average. Its robust liquidity position shows the company's good management of working capital and adeptness at cash flow management. The firm's persistent capacity to create favorable free cash flows reinforces its solvency position, allowing it to effectively manage its debt obligations and allocate resources towards expansion activities, as seen in Figure 3. Its profitability most prominently reflects the financial prowess of J&J. Johnson & Johnson has continuously demonstrated a commendable capacity to create returns, with profit margins that are frequently above those of its industry counterparts. The company's extensive range of products, effective operating procedures, and wide market coverage have regularly resulted in significant sales and profits, highlighting the effectiveness of its business strategy. Johnson & Johnson's investment strategy is characterized by a combination of strategic decision-making and a steadfast dedication to achieving sustained growth over an extended period. Their investment methods frequently involve internal research and development initiatives and external endeavors, such as acquisitions and collaborations. The company has expanded its product range, reached new market niches, and accessed cutting-edge technologies through recent acquisitions. Despite requiring big financial investments, the merger and acquisition (M&A) endeavors undergo a thorough evaluation to assure congruence with the organization's long-term strategic objectives and offer considerable financial gains. Johnson & Johnson's prudent financial judgments extend beyond acquisitions. The company's capital allocation strategy constantly emphasizes reinvestments into the business and shareholder returns. J&J employs a strategic approach encompassing the allocation of dividends, share buybacks, and reinvestments, effectively gratifying its shareholders and concurrently stimulating prospective expansion. Several factors, such as regulatory modifications, patent expirations, and the unpredictable nature of global marketplaces, can influence the financial well-being of the corporation. However, Johnson & Johnson's proactive approach to managing risks, along with its diverse sources of revenue, serves as a protective measure against these issues. This ensures that 24 ARC Advisory. (2020). Johnson &Johnson’s Industrial IoT Strategy for Manufacturing and Predictive Maintenance. Retrieved from: https://www.arcweb.com/blog/johnson-johnsons-industrial-iot- strategy- manufacturing-predictive-maintenance 18
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J the company maintains its financial strength even in the face of adverse conditions within the business. Figure 3: Financial Overview 25 Market Sector Johnson & Johnson, a company with a history spanning over a century, has cultivated a wide-ranging consumer base encompassing diverse demographic groups and geographical areas. The extensive customer base shows the company's diverse range of products catering to various health and wellness requirements. Johnson & Johnson's wide range of products, including those designed for infant care that appeal to young parents and advanced pharmaceuticals tailored to specific patient populations, significantly impact the lives of countless individuals daily, potentially reaching millions, if not billions, of people. 26 The company's consumer health sector addresses individuals' general well-being requirements, offering a diverse range of products spanning skincare items to over-the-counter medications. Johnson & Johnson has garnered notable standing in the pharmaceutical industry due to its endeavors in developing innovative medications that effectively target significant medical ailments. These advancements cater to a patient population that actively seeks state-of-the-art therapeutic interventions. 25 Johnson & Johnson ( 2022, July 19 ). Johnson & Johnson Reports Q2 2022 Results. Retrieved from: https://www.jnj.com/johnson-johnson-reports-q2-2022-results 26 Jirásek, M., & Bílek, J. (2018). The organizational life cycle: review and future agenda. Quality Innovation Prosperity. 19
ORGANIZATIONAL ANALYSIS OF J&J The primary advantage of Johnson & Johnson is its capacity to serve diverse demographic segments effectively. The company's baby care range primarily focuses on young families and parents, while its skincare products are designed to meet the needs of younger individuals seeking preventive care and older individuals seeking therapeutic skincare treatments. The company's pharmaceutical products are designed to meet the diverse requirements of different age groups, medical conditions, and patient needs, owing to their extensive range. 27 Johnson & Johnson's wide portfolio allows for a significant market presence across many segments, ensuring a dominant market share. Within the realm of over-the-counter wellness, these entities have prominent positions as market leaders, boasting globally recognized goods that have become household names. The medical devices division also holds a substantial portion of the market, particularly in specialized areas where they provide distinctive and pioneering solutions. The pharmaceutical industry, characterized by intense competition and rapid advancements, observes J&J consistently pushing the limits to sustain a substantial market presence by regularly introducing pioneering treatments. Despite fierce competition across all operational sectors, the company has established a strong position via its unwavering dedication to quality, innovation, and brand trust. Johnson & Johnson's comprehensive knowledge of its target demographics and ability to engage in innovative practices that align with customer demands enables the company to maintain a substantial market share across its diverse product categories. Technology Sector Johnson & Johnson utilizes a strong technical framework that serves as the fundamental support for its many activities, including operations, research endeavors, and interactions with consumers. The infrastructure is specifically built to facilitate the intricate procedures involved in drug research and medical device innovation while addressing the current needs of data analysis, digital marketing, and customer relationship management. Incorporation of sophisticated computer techniques, such as artificial intelligence (AI) and machine learning, is progressively being assimilated into drug discovery pipelines to forecast molecular behaviors and patient responses. Within the field of medical equipment, the company employs advanced production technologies that guarantee accuracy, dependability, and the potential to be scaled up. The consumer health business of Johnson & Johnson is becoming increasingly dependent on digital platforms, encompassing e-commerce solutions and digital marketing tools. This strategic approach allows the company to maintain connectivity with its worldwide customer base and deliver tailored solutions. In light of the rapid advancement of technology and the considerable opportunities for collaboration, Johnson & Johnson has established several strategic alliances with technology companies, emerging enterprises, and academic institutions. These collaborations aim to use the potential of emerging technologies, encompassing data analysis, AI-driven research, and digital health solutions. As an illustration, the company's cooperation 27 IFAC. (2019). Building data science and analytics capabilities in finance and accounting.Retrieved from: professionals/discussion/building-data-science-and-analytics-capabilities-finance-and accountin 20
ORGANIZATIONAL ANALYSIS OF J&J with technology entrepreneurs in digital health has resulted in the creation of wearable gadgets and mobile applications that oversee patient well-being, facilitate remote healthcare consultations, and improve medication compliance. 28 These tools improve patient outcomes and provide useful data that can be utilized in research pipelines, thereby establishing a circle of ongoing enhancement. Johnson & Johnson has multiple internal centers of excellence focused on technology innovation. These internationally dispersed hubs serve as collaborative spaces where interdisciplinary teams convene to engage in ideation, prototyping, and developing innovative solutions that integrate healthcare and technology. The individual's proficiencies in biotechnology, data science, and digital health solutions situate them at the front of the healthcare sector's continuous digital revolution. Economic Sector Johnson & Johnson operates within the global market, rendering it vulnerable to a range of macroeconomic factors that have the potential to impact its operations, profitability, and growth strategies. In areas characterized by elevated inflation rates, customers may tend to curtail their expenditures on discretionary goods, which could encompass certain consumer health items offered by Johnson & Johnson. It affects the expenses associated with acquiring raw materials and conducting industrial processes within the organization. Modest inflation may be perceived as a signal of a robust economy, fostering heightened consumer expenditure and confidence. Johnson & Johnson's funding decisions are influenced by the interest rates established by central banks in various nations. 29 When interest rates are lower, it becomes more economically feasible for companies to obtain loans, which may encourage them to make expenditures in research and development, acquisitions, or growth initiatives. On the other hand, elevated interest rates can augment the expenses associated with borrowing, inducing a sense of prudence inside the organization regarding utilizing financial leverage. Gross Domestic Product (GDP) growth serves as a pivotal metric. As nations undergo economic expansion, as seen by an upward trajectory in GDP, there tends to be a corresponding augmentation in healthcare expenditure, encompassing governmental and individual outlays. The expansion has the potential to generate increased market opportunities for Johnson & Johnson throughout its diverse portfolio, encompassing medicines, medical equipment, and consumer health products. While vital healthcare products may demonstrate resilience during economic downturns, it is anticipated that certain consumer goods manufactured by Johnson & Johnson may experience a decline in sales. Recessions diminished healthcare budgets in certain countries, potentially impacting the company's higher-cost medical devices or therapies. Economic upswings have the potential to initiate phases characterized by heightened expenditures on healthcare and overall welfare. Affluent societies exhibit a greater inclination to allocate resources towards sophisticated 28 Karim, S., & Mitchell, W. (2004). Innovating through acquisition and internal development: A quarter-century of boundary evolution at Johnson & Johnson. Long Range Planning. 29 Boland, R. (2018). How J&J uses consumer data to enhance the customer experience. Retrieved from: https://mackinstitute.wharton.upenn.edu/2018/consumer-data-robert-boland/ 21
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J healthcare solutions, resulting in expanding markets for Johnson & Johnson's innovative medical solutions and wellness products. The implementation of economic policies, such as trade tariffs, has the potential to influence a corporation's operations and performance. For example, implementing tariffs on imported items can raise the expenses of acquiring raw materials or completed products, exerting pressure on profit margins and necessitating price modifications. Government Sector The pharmaceutical and healthcare industry, in which Johnson & Johnson holds a prominent position, is widely recognized as one of the most extensively regulated sectors globally. The need for this rigorous supervision is attributed to the significant influence these goods exert on the overall welfare and health of the general population. Johnson & Johnson must effectively navigate the complex legal landscape by comprehending diverse legislation across different markets and maintaining a steadfast commitment to constant compliance. One notable facet of the prevailing regulatory framework pertains to approving pharmaceutical drugs by the government. Before being launched to the market, any novel pharmaceutical or medical apparatus must undergo a comprehensive examination and assessment process by regulatory agencies, such as the U.S. Food and Drug Administration (FDA). These assessments guarantee the product's ingestion safety and efficacy in fulfilling its medicinal claims. 30 Johnson & Johnson regularly interacts with regulatory agencies to obtain authorization for its innovative products. Patents enable Johnson & Johnson to safeguard its innovative developments, affording them exclusive privileges to manufacture and commercialize a certain pharmaceutical or apparatus for a predetermined duration. Exclusivity is critical in recovering the expenses associated with research and development and guaranteeing profitability. The corporation must remain diligent in safeguarding its intellectual property rights in different jurisdictions due to the global variations in patent rules. Consumer health regulations represent a crucial aspect of the legal framework. The laws apply to non-prescription products, aiming to guarantee their safety for public use and ensure that their marketing and labeling adhere to standards of clarity, accuracy, and non-deceptiveness. Considering its extensive range of products and presence in the global market, ensuring regulatory compliance emerges as a crucial operational issue for Johnson & Johnson. The organization maintains specialized teams establishing communication channels with regulatory entities, guaranteeing compliance with domestic and global regulations throughout the product lifecycle, from initial development to market introduction. 31 Adopting this proactive approach guarantees the unimpeded entry of items into the market and enhances the company's standing as a reliable leader in the industry. Lobbying is another facet of Johnson & Johnson's engagement with the governmental sphere. Although lobbying may have various associated implications, its 30 Williams, O. F., & Murphy, P. E. (1990). The ethics of virtue: A moral theory for marketing.Journal of Macromarketing. 31 Data Center Solution Johnson Controls. (2023, Oct 08). Retrieved from: https://www.johnsoncontrols.com/buildings/specialty-pages/engineer-design-center/data- center-solution 22
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J fundamental purpose is to exert influence on policy-making processes in order to promote innovation, guarantee patient accessibility to vital medications, and establish a favorable climate for the expansion of the healthcare industry. Johnson & Johnson, a company of significant industry prominence, actively participates in endeavors to influence regulations that align with its purpose of enhancing health outcomes and maintaining a viable business model. The lobbying endeavors of the corporation extend beyond the realms of drug approvals and patents. These concerns span a wide array of topics, including healthcare reform and trade policies, so guaranteeing that the company's voice and knowledge play a significant role in establishing a comprehensive and efficient healthcare environment. Sociocultural Sector Johnson & Johnson represents more than a mere corporate organization; rather, it has established itself as a prominent brand deeply ingrained in households across the globe. The company's diverse product portfolio profoundly impacts individuals' lives daily, from infant care items to critical pharmaceuticals. The perception of the general population significantly influences the success of the endeavor. The company engages with local communities through various programs and partnerships. These initiatives often address community-specific needs, such as access to healthcare services, education, and job opportunities. Johnson & Johnson has a longstanding commitment to corporate social responsibility. It supports various social and cultural initiatives, including philanthropic and community outreach programs. These initiatives often aim to improve healthcare access, promote health and wellness, and address societal issues. The company is largely involved in various health education programs to promote public health awareness and education. These programs often target various health-related issues, from maternal and child health to disease prevention and wellness promotion. Throughout several decades, Johnson & Johnson has actively fostered a reputation characterized by qualities of dependability and reliability. The organization's dedication to maintaining high quality and safety standards has established itself as a reliable supplier of healthcare and consumer goods. 32 Periods of public scrutiny have been prompted by occasional product recalls or legal difficulties. However, the organization's commitment to open and honest communication in addressing issues, together with its unwavering focus on the welfare of consumers, has significantly contributed to the preservation of a favorable corporate reputation. Johnson & Johnson's dedication to its consumers is underscored by implementing the "Our Credo" philosophy, which prioritizes meeting the needs and ensuring the well-being of the individuals they serve. The enduring belief system has consistently influenced their operational strategies and decision- making procedures, strengthening the company's reputation as a brand that demonstrates concern. In addition to its business endeavors, Johnson & Johnson has demonstrated a notable 32 Schuhmacher, A., Wilisch, L., Kuss, M., Kandelbauer, A., Hinder, M., & Gassmann, O. (2021). R&D efficiency of leading pharmaceutical companies–A 20-year analysis. Drug Discovery Today. 23
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J dedication to philanthropy and social responsibility. The company's corporate social responsibility (CSR) efforts indicate its commitment to positively influencing society. These activities encompass a wide spectrum of efforts, ranging from global public health programs that seek to combat infectious diseases worldwide to local community outreach projects that specifically target and address acute needs within a particular community. An exemplary initiative undertaken by the organization is its dedication to enhancing the well-being of mothers and infants. Through strategic collaborations with international organizations and utilizing its available resources, Johnson & Johnson has significantly contributed to reducing infant mortality rates and improving maternal well-being in places particularly susceptible to vulnerabilities. In addition, the philanthropic endeavors of the corporation encompass initiatives aimed at assisting in times of natural or artificial disasters. Johnson & Johnson consistently demonstrates a prompt and proactive response when confronted with natural disasters, promptly offering vital resources, pharmaceuticals, and assistance to impacted populations. Johnson & Johnson has demonstrated significant responsibility in the realm of environmental stewardship as well. The company's overarching objective encompasses sustainable operations, the mitigation of carbon footprints, and the promotion of eco-friendly product designs, all aimed at improving the environment. International Sector Johnson & Johnson is a brand with exceptional global reach across healthcare and consumer items. Having established its origins in the United States, the organization has expanded its presence to encompass various geographical locations worldwide. Johnson & Johnson's presence is widespread, spanning from the vibrant marketplaces of Asia to the varied landscapes of Africa and from the well-established economies of Europe to the developing centers in Latin America. An organization's comprehensive worldwide reach is not limited to possessing a distribution network across several nations. Instead, it encompasses establishing fully functional operations encompassing research and development, manufacturing, and sales. 33 The regional hubs of the organization are designed to address the specific demands of local communities, guaranteeing that items are not only imported but also customized and occasionally even created with consideration for particular preferences and requirements. Implementing localized methods has played a crucial role in enabling Johnson & Johnson to effectively connect with a wide range of consumers, surpassing cultural and geographical limitations. Operating in the global market is multifaceted since it involves managing a wide range of cultural, legislative, and economic factors that exhibit significant variances. The success of Johnson & Johnson in this domain can be attributed to its astute comprehension of regional intricacies coupled with its extensive worldwide proficiency. In emerging economies, where healthcare infrastructure may still be in the formative stage, Johnson & Johnson has demonstrated a proactive approach by supplying products and supporting training and education initiatives for healthcare workers. The 33 Statistica. Johnson & Johnson's top pharmaceutical products by sales. Retrieved from: https://www.statista.com/statistics/266405/global-revenue-of-johnson-und-johnsons-pharmaceutical-segment-by- product/ 24
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J comprehensive approach implemented by the company has not only resulted in increased revenue but has also established the organization as a valuable contributor to the advancement of healthcare in numerous countries. The firm strategically utilizes its extensive range of products within well-established industries to drive innovation and introduce cutting-edge solutions. This applies to the pharmaceutical and medical device sectors, as the company aims to meet the ever- changing demands of discerning consumer populations. Johnson & Johnson has consistently incorporated regional alliances into its strategic approach, whether through collaboration with local entities or governmental agencies. These collaborative efforts facilitate more streamlined regulatory processes, improved market access, and increased customer confidence. In terms of performance, the overseas ventures undertaken by the corporation have yielded positive results. Internal Environment The internal environment of an organization includes processes and systems within its direct control. The analysis of Johnson & Johnson provides valuable insights into its fundamental competencies, areas that could be enhanced, and the internal dynamics that shape its strategic decisions. Management Johnson & Johnson possesses a multifaceted and efficient organizational framework. The corporation is decentralized, with distinct parts dedicated to different product lines, encompassing pharmaceuticals and consumer health. The executive board, led by the Chief Executive Officer (CEO), offers comprehensive strategic guidance. Beneath the uppermost echelons of leadership are distinct departmental divisions, each possessing its unique array of tasks and decision-making powers. Utilizing a hierarchical and segmented framework enables expeditious decision-making processes and provides the opportunity to formulate market- specific strategies at a regional scale. Promoting independence within individual departments also guarantees coherence with the organization's overarching goals, thus establishing a harmonious equilibrium between centralized authority and decentralized adaptability. The leadership structure of Johnson & Johnson is characterized by a combination of various styles specifically designed to address the distinct difficulties and possibilities that arise within the healthcare sector. The presence of a robust aspect of transformational leadership is particularly notable, particularly within the highest levels of the organization, where the ability to provide a clear vision, inspire others, and demonstrate strategic foresight is of utmost importance. Leaders motivate teams by effectively communicating a collective vision, particularly aligning with the organization's guiding principle of prioritizing the needs of patients and consumers. The utilization of a situational leadership approach is commonly observed, particularly in the ever- changing healthcare environment, to ensure that leadership styles are tailored to suit specific situations and the team's requirements. The organization utilizes a meticulous procedure that 25
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J combines evidence-based analysis with practical expertise. 34 The executive board is often the primary source of key company decisions, particularly those with wide-ranging ramifications. The company's decentralized structure facilitates decision-making at the departmental or regional level, enabling the organization to adapt and respond to unique market intricacies swiftly. The feedback loop is a crucial component of the decision-making matrix as it facilitates the dissemination and incorporation of insights, problems, and learnings from various markets or departments into the overarching strategies of the firm. This responsive method guarantees the organization's adaptability to market dynamics, competitive pressures, and internal input. Establishing and maintaining efficient communication channels is a fundamental pillar for the successful functioning of Johnson & Johnson's worldwide operations. The corporation utilizes various tools and platforms, encompassing conventional channels such as internal newsletters and town hall meetings, as well as contemporary digital platforms, intranets, and collaborative tools. These media perform a dual function. Openness is maintained by providing staff with up- to-date information regarding corporate advancements, accomplishments, and obstacles. They facilitate cooperation by enabling cross-functional teams in various locations to work effectively. The efficacy of these communication channels is apparent in the organization's capacity to sustain unity, foster collective engagement, and cultivate a common sense of mission across its extensive and heterogeneous staff. Marketing Johnson & Johnson strategically develops marketing strategies specifically customized to each of its many segments, including pharmaceuticals, consumer health, and medical equipment. A fundamental aspect of their marketing planning is a comprehensive comprehension of their target demographic. For example, pharmaceutical advertisements prioritize healthcare professionals and patient advocacy groups as their primary audience, whereas consumer health campaigns tend to target end customers directly. The choice of media outlets corresponds to the intended audience segments, with digital platforms catering to younger demographics, traditional print and TV channels targeting a wider audience, and specialized medical periodicals serving the professional community. The key message development is grounded on thorough market research, which guarantees its alignment with the target audience and emphasizes the company's dedication to excellence, creativity, and attentiveness. Assessing the effectiveness of marketing efforts holds significant importance for Johnson & Johnson. Brand recall surveys are valuable tools that offer information into the level of memorability and impact of campaigns within the competitive healthcare sector. Sentiment research, frequently conducted through sophisticated analysis on digital platforms, provides insights into the prevailing public perception, while sales numbers provide a concrete indication of the efficacy of a campaign. Johnson & Johnson possesses a robust brand reputation frequently linked to reliability and excellence, which is evidence of its enduring and successful marketing initiatives throughout its history. Johnson & 34 Jirásek, M., & Bílek, J. (2018). The organizational life cycle: review and future agenda. Quality Innovation Prosperity. 26
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Johnson has made substantial investments in expanding its online presence. 35 The digital marketing methods employed by the organization consist of a combination of informational material, interactive platforms, and direct engagement tactics. Their digital initiatives encompass a range of strategies, such as utilizing social media platforms to launch novel products, conducting webinars targeted at healthcare professionals, and employing search engine marketing techniques to enhance online sales. The primary objective of these undertakings is to foster active involvement and impart knowledge. Metrics, including click-through rates, website stay time, and social media shares, provide valuable insights into the efficacy of digital activities. Johnson & Johnson routinely demonstrates a strong online engagement in the healthcare industry, reflecting its high position. Customer feedback plays a crucial part in influencing the marketing strategies employed by Johnson & Johnson. The organization establishes and maintains a bidirectional communication relationship with its consumers by utilizing conventional approaches such as focus groups and contemporary means like online feedback forms. Johnson & Johnson's marketing strategy is multifaceted and personalized to each business segment. For instance, the company strongly emphasizes building and maintaining a positive brand image and reputation. They often use their company principle, which emphasizes a commitment to customers, employees, and the community, as a central theme in their branding and marketing efforts. Johnson & Johnson operates in several sectors as a pharmaceutical company, so they use a diversified marketing approach. Their pharmaceutical, medical devices, and consumer health segments have unique marketing strategies targeting different audiences. The company also invests heavily in research and development, highlighting their innovative products and solutions in their marketing campaigns. Johnson & Johnson has adopted digital marketing channels to reach and engage with customers per the current market demands to maintain its competitiveness. They have a strong online presence, including social media, websites, and email marketing platforms. Content marketing, which has become a trend recently, is also adopted in their strategy. They do so by creating and sharing content related to health and wellness, providing information and education to their target audience. Johnson & Johnson often participates in community and social responsibility initiatives, and they incorporate these efforts into their marketing. These initiatives include healthcare-related projects, sustainability, and more that directly or indirectly impact the community. The company also engages in healthcare professional outreach, whereby the pharmaceutical and medical devices segments engage with healthcare professionals through various marketing channels, including conferences, workshops, and online resources to reach the consumer. Johnson & Johnson focuses on connecting with consumers through advertising and promotions. They often run campaigns promoting trust and the quality of their products. As a global company, Johnson & Johnson tailors its marketing strategies to specific regions and 35 Karim, S., & Mitchell, W. (2004). Innovating through acquisition and internal development: A quarter-century of boundary evolution at Johnson & Johnson. Long Range Planning. 27
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J countries. This may involve adapting products, packaging, and messaging to meet local preferences and regulations. For the company's crisis management strategy, Johnson & Johnson is committed to dealing with product recalls and legal issues in the past. Their marketing strategies include addressing such crises transparently and rebuilding trust with their consumers, shareholders, employees, and other interested parties. The feedback loop yields valuable knowledge regarding the product's efficacy and potential areas for enhancement and impacts forthcoming marketing initiatives. For example, if a given product consistently garners feedback regarding a particular feature, subsequent marketing efforts may strategically emphasize and prioritize the promotion of said feature. The response of Johnson & Johnson to feedback highlights its dedication to a customer-centric approach, thereby assuring the alignment of its marketing plans with the evolving requirements and preferences of consumers. Production/Operation The supply chain of Johnson & Johnson is carefully orchestrated to optimize operational effectiveness and dependability. The organization has cultivated enduring partnerships with essential suppliers, guaranteeing a consistent flow of high-quality raw materials. The company's logistics methods are designed to accommodate the needs of both domestic and global markets, focusing on ensuring prompt delivery and reducing the potential for product deterioration during transportation. Inventory management procedures involve the strategic control of storage costs and product availability. This is achieved by combining forecasting models and real-time data analysis. Integrating these collaborative activities guarantees a smooth progression from the procurement of raw materials to the final distribution of the finished product, emphasizing the organization's dedication to achieving operational superiority. Metrics such as 'Output per Labor Hour' and 'Capacity Utilization' are consistently examined to maintain the highest level of resource utilization. The company has consistently committed to integrating cutting-edge production advances throughout its history. One example of the impact of automation is the reduction of manual errors in jobs requiring high precision. Artificial intelligence (AI) powered predictive analysis plays a crucial role in estimating future demand, thereby facilitating the optimization of production schedules. 36 In addition, Johnson & Johnson has adopted lean manufacturing methodologies, which involve the elimination of inefficiencies and superfluous activities, optimizing resource allocation towards activities that contribute value. The organization has implemented stringent processes, including several stages, such as raw material inspection and post-production tests, to guarantee the product's safety, uniformity, and efficacy. Every production plant is equipped with advanced laboratories and staffed by professional quality assurance teams who rigorously evaluate items according to set standards. The regular occurrence of audits, conducted internally and by regulatory agencies, reinforces their steadfast dedication to maintaining high standards of quality. Incorporating feedback loops involving healthcare professionals and end consumers serves to gather real-world data, assuring that 36 Liu, Z. (2023). The Financial Statement Analysis of Johnson and Johnson. Highlights in Business, Economics and Management. 28
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J products meet and surpass expectations. 37 Johnson & Johnson has demonstrated a commendable commitment to environmental stewardship by implementing substantial measures to enhance sustainable production practices. Efforts encompass various dimensions, including acquiring raw materials from sustainable and ethical sources, optimizing production processes to mitigate waste generation, and using environmentally friendly packaging alternatives. The emphasis is placed on energy usage, as manufacturers progressively rely on renewable energy sources to meet their power needs. In addition, waste management regulations emphasize the practice of recycling and the transformation of trash into forms that have increased value. These programs bolster the company's public perception while highlighting its sincere dedication to environmental well- being, aligning with its overarching objective of safeguarding human health. Finance/Accounting Johnson & Johnson has a strong budgeting and planning mechanism for its financial system. The planning process is guided by detailed forecasting models informed by market trends, historical data, and global economic indicators. This measure guarantees that departments have sufficient funding to pursue short-term goals and long-term expansion effectively. For example, a considerable allocation of resources is regularly dedicated to research and development (R&D) to promote future innovation. Simultaneously, equal importance is placed on marketing efforts to achieve quick market penetration and enhance brand visibility. The allocation of contingency money serves as evidence of the company's proactive approach to financial planning, specifically in anticipation of unforeseen obstacles. The financial discipline of Johnson & Johnson is apparent through its well-diversified investment portfolio. 38 A simultaneous emphasis on short-term gains and long-term value creation guides capital allocation. Strategic acquisitions serve as a means to enhance a company's product portfolio and extend its market presence across different geographical locations. Investments in research and development (R&D) hold the potential to generate future revenue streams by introducing innovative and groundbreaking items. Risk management is a fundamental component of their financial strategy. The corporation protects shareholder interests by implementing an investment diversification strategy and maintaining a favorable debt-to-equity ratio. The collective activities continuously result in advantageous returns on investment, with Johnson & Johnson consistently surpassing the industry benchmarks. In order to maintain its standing as a transparent and ethical organization, Johnson & Johnson lays significant emphasis on the audit and compliance processes. The internal audit procedures implemented by the company are characterized by a high level of rigor, ensuring that the financial statements effectively and accurately reflect the organization's fiscal well-being. These audits are complemented by external assessments carried out by reputable accounting firms, ensuring an additional level of scrutiny. In addition, the 37 Alhosnai, K., Kharbanda, K., Almazrouei, H. S., Alzaabi, A. I., Aldhanhani, W., Mostafa, S., ... & Nobanee, H. (2021). Financial analysis of Johnson & Johnson in light of the COVID-19 vaccination research developments. 38 Liu, Z. (2023). The Financial Statement Analysis of Johnson and Johnson. Highlights in Business, Economics and Management. 29
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J extensive global reach of Johnson & Johnson necessitates the management of a complex network of financial rules. Compliance teams that are specifically designated assure strict adherence to regional and international standards, encompassing a wide range of regulations such as tax rules and financial reporting processes. 39 The attention to detail exhibited in this approach mitigates regulatory consequences and bolsters stakeholder confidence and reliance. Johnson & Johnson's connection with its stakeholders is built upon transparent and timely communication principles. From quarterly updates to yearly disclosures, financial reports include comprehensive company performance analysis, strategies, and prospects. During adversity, such as a decline in the market or unexpected expenses, the company promptly offers relevant information to address shareholder apprehensions. Annual shareholder meetings, webinars, and investor relations portals enhance bilateral communication. The dedication to transparency exhibited by Johnson & Johnson serves the purpose of providing stakeholders with the necessary information and bolstering their trust in the company's financial responsibility and future growth prospects. The corporation disclosed a cumulative yearly revenue above $82 billion in 2021, indicating a sustained upward trend in its financial expansion. The corporation allocated roughly 13% of its entire revenue, equivalent to approximately $10.6 billion, towards these endeavors. The diverse investment portfolio of Johnson & Johnson, along with its proactive approach to risk management, led to a noteworthy return on equity (ROE) of 28.5%, surpassing industry benchmarks by a substantial margin, as seen in the figure below. Figure 4: J&J Revenue in 2021 Research & Development Johnson & Johnson's research and development (R&D) section maintains a strong track record of providing innovative goods to the market, demonstrating a keen awareness of evolving 39 Eaddy, L. L. (2012). Johnson & Johnson's Recall Debacle. 30
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J healthcare demands. The organization can forecast changes in consumer preferences, medical patterns, and worldwide health issues by conducting extensive market research and utilizing predictive analysis. Consequently, the organization's research and development (R&D) portfolio is abundant, with various projects encompassing advanced pharmaceutical solutions and state-of- the-art medical devices. The company's R&D strategy is integral to its mission of improving the health and well-being of people worldwide. Johnson & Johnson places innovation at the core of its R&D strategy. Innovation is seen as a means to address unmet medical needs, develop novel healthcare solutions, and improve patient outcomes in the company. To create a robust and diversified portfolio, the company continuously invests in cutting-edge research across multiple sectors, including pharmaceuticals, medical devices, and consumer health. One key feature of Johnson & Johnson's R&D strategy is collaboration. The company actively seeks external partnerships with academic institutions, startups, and other industry players. These collaborations help facilitate access to new ideas, technologies, and expertise. By working with a wide network of partners, Johnson & Johnson can tap into a broad spectrum of innovation and stay at the forefront of healthcare advancements. Another significant aspect of the company's R&D strategy is its commitment to translational research. This approach aims to bridge the gap between early-stage discoveries and real-world applications. Johnson & Johnson strives to accelerate the translation of scientific insights into tangible products and treatments that can make a difference in patient care. A patient-centric focus underpins Johnson & Johnson's R&D strategy. The company actively engages with patients and healthcare professionals to understand their needs, preferences, and experiences. This patient-centered approach guides the development of products and services, ensuring that they address real-world healthcare challenges and provide value to end-users. The company also places a strong emphasis on ethical and responsible R&D practices. Johnson & Johnson's research activities uphold high quality, safety, and compliance standards. This commitment is essential in ensuring that the products developed meet regulatory requirements and are safe for patients and consumers. Johnson & Johnson's global presence and reach are crucial to its R&D strategy. The company operates R&D facilities and collaborations in numerous countries, leveraging diverse talent and perspectives. This global footprint enables the company to adapt and respond to regional healthcare needs while maintaining a global perspective on healthcare innovation. A dedication to innovation, collaboration, translational research, patient-centricity, ethics, and global engagement characterizes Johnson & Johnson's R&D strategy. These elements collectively drive the company's mission to discover and develop healthcare solutions that improve the lives of individuals worldwide. By fostering a culture of innovation and maintaining a relentless focus on R&D, Johnson & Johnson continues to play a pivotal role in advancing healthcare and addressing the evolving challenges of the healthcare industry. These inventions can potentially strengthen Johnson & Johnson's market position and testify to its dedication to raising global health standards. Johnson & Johnson's remarkable assortment of patents is a tribute to the company's pioneering ethos. The company's intellectual 31
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J research is protected, and its competitive advantage is secured through patents covering several healthcare industry fields. Each patent symbolizes extensive research efforts spanning several years, offering potential commercial advantages and significant progress in healthcare solutions. Moreover, the strategic areas of emphasis delineated by these patents, encompassing biotechnological advancements and digital health instruments, serve as a testament to Johnson & Johnson's forward-looking perspective on the trajectory of healthcare. The patents possess significant commercial value, guaranteeing consistent cash streams and strengthening the company's competitive advantage. Recognizing the significance of common knowledge and skills, Johnson & Johnson aggressively pursues collaborative endeavors. Collaborations with academic institutions contribute to research endeavors by incorporating rigorous academic standards, whereas affiliations with startups inject agility and fresh viewpoints into the research and development (R&D) processes. Johnson & Johnson's research skills are significantly enhanced through collaboration with other corporate organizations, particularly those operating in complementary fields such as technology or artificial intelligence. Establishing these collaborative partnerships expedites the invention process, enriches the scope of research, and guarantees that Johnson & Johnson maintains its position at the forefront of healthcare breakthroughs. Johnson & Johnson's research and development initiatives are driven by a steadfast dedication to upholding research ethics. All projects, including developing new medication formulations or medical device prototypes, are subject to rigorous ethical reviews. Clinical trials are carefully designed and organized with great detail to prioritize participants' safety, obtain informed permission, and maintain the data's integrity. Maintaining transparency is a fundamental aspect of the research process, ensuring that openness and clarity are upheld from the initial formulation of hypotheses through the eventual release of results. By adhering to these stringent ethical standards, Johnson & Johnson ensures the dependability and safety of its products and strengthens public confidence in its research initiatives. The company allocated nearly 12% of its yearly revenue, surpassing $10 billion, to support R&D activities, as illustrated in Figure 5. The organization maintains a comprehensive network comprising over one thousand relationships, leading to the initiation of more than two hundred and fifty ongoing clinical trials. The company's product development is guided by a patient-centric strategy, which involves active engagement with a substantial number of patients and healthcare professionals, exceeding 300,000. The commitment of Johnson & Johnson to upholding ethical research and development (R&D) principles is evident through their rigorous ethical evaluations and comprehensive processes for conducting clinical trials. The corporation possesses a noteworthy collection of more than 75,000 patents, safeguarding its intellectual assets and augmenting its competitive edge within the healthcare industry. Johnson & Johnson, a multinational corporation, maintains a widespread research and development network across more than 60 countries. This extensive presence positions the company as a prominent entity in advancing healthcare innovation and enhancing patient care while adhering to rigorous ethical research protocols. 32
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Figure 5: R&D Expenditure Organizational Design for an International Environment Working in over 60 nations, J&J has organized its worldwide divisions to have great independence. This approach permits these divisions to fit their techniques and activities to suit neighborhood economic situations. Figure 6: Leadership 33
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Johnson and Johnson (J&J) is a global organization that works in three significant fragments: drugs, customers, and clinical gadgets. J&J has a worldwide association structure that permits each working organization to join forces with the line of the board and influence provincial and practical mastery. J&J likewise has focused on greatness and class groups that emphasize unambiguous areas of expenditure and acquisition, like synthetic compounds, development, counseling, outer assembling, and data innovation. These groups expect to give uncommon quality, administration, development, and maintainability to J&J organizations and clients. 40 J&J's hierarchical plan upholds its technique of remaining imaginative and tracking down answers for the most significant neglected needs in medical services. J&J uses the best of science and innovation to foster items that expand lives and work on the personal satisfaction of individuals all over the planet. J&J's hierarchical plan likewise mirrors its obligation to morals and consistency, as it has a worldwide consistency program screen, surveys, and further develops its center projects and cycles and uses information, measurements, investigation, and innovation. J&J's hierarchical plan empowers it to adjust to the changing medical services climate and answer unforeseen difficulties, like the Coronavirus pandemic. J&J could move consistently into remote work and oversee needed changes in a representative commitment by having clear responsibility and coordinated effort across its groups. The organization has a decentralized 40 Williams, O. F., & Murphy, P. E. (1990). The ethics of virtue: A moral theory for marketing. Journal of Macromarketing. 34
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J hierarchical design that permits each section and auxiliary to have independence and adaptability in answering the different necessities of the global business sectors; this construction likewise works with quicker direction and more representative strengthening, as lower-level chiefs have greater power and obligation. Notwithstanding, a decentralized design likewise represents a few difficulties, like failures and correspondence breakdowns, which Johnson and Johnson attempt to defeat by executing an essential structure and local groups. One of the ways that Johnson and Johnson use its decentralized design is by focusing on greatness (CEOs) in various locales for backhanded obtainment, which are labor and products that are not straightforwardly utilized in an item, for example, counseling, showcasing, and travel. These CEOs expect to streamline the spending and execution of the organization by utilizing the information, framework, and best acts of every area. Another way that Johnson and Johnson benefits from its decentralized construction is by delegating classification pioneers and groups for direct obtainment, which are labor and products that are straightforwardly utilized in an item, like synthetic substances, biologics, and outer assembling. These classification groups are liable for building an extraordinary provider network that gives quality, advancement, administration, and supportability to the organization's organizations. One of the difficulties of the authoritative plan for a worldwide climate is to adjust the requirement for worldwide combination and neighborhood responsiveness. Johnson and Johnson, a global enterprise in more than 60 nations, has taken on a decentralized design that permits its auxiliaries to adjust to various business sectors' particular requirements and inclinations. One illustration is the coordinated effort between Johnson and Johnson and Legend Biotech, an auxiliary of GenScript Biotech Company, in China. Products and Services Johnson & Johnson, a renowned company recognized for its advancements in the healthcare industry, possesses an extensive and varied range of products and services as shown in Figure 7. Initially specializing in producing surgical dressings, it has expanded its operations to include three prominent sectors: Consumer Health, Pharmaceuticals, and Medical Devices. Each field shows the company's dedication to improving human health. The general public widely recognizes the Consumer Health section, encompassing various products, including skincare items, over-the-counter pharmaceuticals, and baby care basics. The Pharmaceuticals division focuses on several aspects of health, such as immunology, neuroscience, and infectious diseases. Its primary objective is to discover and market pharmaceuticals that have the potential to revolutionize medical treatments. The Medical equipment category primarily centers on various instruments, orthopedic items, and cardiovascular equipment essential to hospital and healthcare professionals' operations. The range of products and services offered by Johnson & Johnson enables the firm to address various market demands effectively. This comprehensive portfolio is also protective, safeguarding the company's stability amid industry-specific downturns. The 35
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J corporation ensures a strong presence in mass markets and niche industries by keeping a well- balanced assortment of daily consumer items and specialized healthcare products. The long-term success of any organization is contingent upon its adeptness in effectively managing the life cycles of its goods. The cycle for Johnson & Johnson commences with a comprehensive research and development process, which culminates in the emergence of significant advancements and breakthrough technologies. As these products are introduced, implementing assertive marketing methods propels them towards the growth phase. Over time, certain products or services, characterized by their exceptional quality or unequaled effectiveness, gradually progress to maturity, contributing to the company's revenue stream. These entities represent the company's most profitable and stable sources of revenue. Consider, for example, Johnson's Baby Shampoo or the adhesive bandage. 41 These products, which have already surpassed their period of rapid expansion, continue to earn stable and predictable revenues. The enduring popularity and established credibility they have garnered over several decades render them indispensable. The consistent revenue generated by these profitable business units enables Johnson & Johnson to allocate resources towards new initiatives, sustaining its innovation cycle. In a time characterized by the dynamic nature of healthcare concerns, Johnson & Johnson demonstrates a proactive approach, refraining from complacency. Its strong research and development (R&D) pipeline shows the organization's proactive stance. Johnson & Johnson is positioned to introduce a new age of healthcare solutions by embracing the possibilities of biotechnology, tailored medicine, and digital health tools. The organization is actively investigating domains beyond conventional medicine, encompassing mental well-being, nutritional supplements, and wearable health technology, to acknowledge the importance of holistic health. Johnson & Johnson's dedication to future breakthroughs is exemplified by its collaborations with technology firms, investments in research driven by artificial intelligence, and relationships with academic institutions. The organization is already building the framework as healthcare paradigms change towards prevention over cure and individualized treatment programs. The next products and services offered by the company not only aim to target specific health issues but also seek to alter the prevailing perception of healthcare. See the figure below for further illustration. Figure 7: Product Diversification 41 Johnson & Johnson. (2023). Johnson & Johnson consumer health. Retrieved from: https://www.jnjcanada.com/explore-our-brands 36
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Information Technology & Control Systems Johnson & Johnson has consistently embraced information technology (IT) to support and advance its strategic objectives. Johnson & Johnson, as a prominent healthcare organization, recognizes the potential of technology as a catalyst for expediting research, improving patient care, and optimizing operational processes. In recent years, Johnson & Johnson (J&J) has made substantial investments in information technology (IT) to enhance its supply chain management, optimize product distribution, and refine its global marketing endeavors. Through data analysis, Johnson & Johnson can proactively predict market trends, customize its products to meet consumer demands, and enhance its ability to address global health concerns. Johnson & Johnson perceives digital transformation as a continuous process rather than a fixed endpoint. The organization has been at the forefront of incorporating cutting-edge technologies to reimagine its business processes and improve customer engagement strategies. Johnson & Johnson (J&J) has implemented mobile applications for patients, digitalized its research and development procedures, and utilized cloud solutions to enhance operational agility. J&J has effectively expanded its global presence by adopting a digital-first strategy, ensuring widespread availability and utility of its products and services across international markets. The preservation of patient data and corporate information has consistently been of utmost importance for J&J. Johnson & Johnson (J&J) has implemented stringent cybersecurity policies in response to the critical nature of the healthcare sector. The organization utilizes advanced encryption techniques, maintains ongoing surveillance of potential threats, and conducts regular security assessments to protect against cyber risks. Ensuring compliance with global data protection legislation is imperative, and Johnson & Johnson has established dedicated teams to ensure that the company's digital initiatives consistently adhere to regulatory standards. 37
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J The dedication of J&J to fostering innovation is demonstrated through its embrace of state-of- the-art technologies. Artificial Intelligence (AI) and Machine Learning (ML) are progressively incorporated into research methodologies, facilitating drug development and modeling clinical trials. These technologies aid J&J in mitigating the time and financial expenses associated with introducing novel solutions to the market. In addition, the Internet of Things (IoT) assumes a crucial function in the medical equipment sector, as it enables the integration of intelligent devices that facilitate the continuous monitoring of patients and the collection of real-time data. 42 These innovations enhance the quality of patient care and provide essential data that can potentially improve health outcomes in subsequent periods. The implementation of Information Technology has had a significant impact on the decision-making processes within J&J. By utilizing real-time data analysis, the organization can promptly make well-informed judgments, regardless of whether they pertain to market fluctuations, manufacturing obstacles, or worldwide health emergencies. Information technology (IT) facilitates the ability of J&J's executives to gain a comprehensive understanding of the various aspects of the company's operations, including supply chains and market dynamics. J&J strategically incorporates information technology (IT) into its fundamental decision-making procedures, ensuring adaptability, promptness, and a forward-thinking stance toward the continuously changing healthcare environment. Johnson & Johnson, as a global healthcare giant, has successfully managed to harness the power of information technology (IT) and control systems to streamline its operations, enhance productivity, ensure compliance, and improve patient care. Johnson & Johnson employs advanced IT systems in managing its complex and extensive supply chain. Using Enterprise Resource Planning (ERP) software, the company can optimize inventory management, production planning, and distribution. This helps reduce costs, improve product availability, and minimize stockouts, ensuring critical healthcare products reach patients when needed. In research and development, the company's IT systems have helped facilitate and analyze vast datasets and streamline the drug discovery process. Johnson & Johnson uses advanced data analysis, modeling, and simulation tools to identify potential drug candidates, speeding up the research and development timeline and, in turn, delivering innovative healthcare solutions. From the results garnered from the research, the healthcare segment of Johnson & Johnson relies on information technology to improve patient care. Electronic Health Records (EHR) systems and Telehealth platforms are examples of IT applications that enable healthcare providers to access patient information securely, communicate with patients remotely, and make more informed medical decisions. These systems are critical in enhancing the company's patient outcomes and healthcare delivery. This ensures that there is quality control and compliance by the company. We use IT-based control systems to ensure the products adhere to stringent quality and safety standards. These systems track and monitor production processes, providing real-time data to promptly control and mitigate quality issues, ensuring that products are consistently safe and effective. 42 Williams, O. F., & Murphy, P. E. (1990). The ethics of virtue: A moral theory for marketing. Journal of Macromarketing. 38
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Data security and privacy are key in the health sector; therefore, several strong IT security measures safeguard patient and company information, including encryption, access controls, and regular security audits. Johnson & Johnson has established a secure environment to protect confidential data, maintaining the trust of both patients and stakeholders. They use the data collected and analyzed for real-time visibility into their supply chain. These systems provide end-to-end traceability, allowing the company to track product movements, monitor temperature- sensitive shipments, and respond to potential disruptions promptly. This ensures product integrity and supports sustainability efforts by reducing waste and energy consumption. Lastly, Effective communication and collaboration are vital for a global organization like Johnson & Johnson. Therefore, the company employs various IT tools such as video conferencing, collaboration software, and cloud-based platforms to connect its workforce seamlessly across different geographies. This ensures that information is shared efficiently, decisions are made collaboratively, and innovative ideas are exchanged freely. Johnson & Johnson's successful utilization of information technology and control systems underscores its commitment to improving healthcare, increasing operational efficiency, and ensuring regulatory compliance. By integrating IT solutions in supply chain management, research and development, healthcare systems, and quality control, the company can deliver high-quality healthcare products and services worldwide. Furthermore, their focus on data security, supply chain visibility, and communication tools exemplifies their dedication to innovation and patient well-being. As the healthcare industry continues to evolve, Johnson & Johnson remains at the forefront by embracing and harnessing the power of information technology and control systems for future success. The company demonstrates a strong dedication to Information Technology (IT) and Control Systems, as seen by its annual investment of over $11 billion in 2021. These expenditures facilitate the integration and analysis of extensive datasets, enabling decision- making and research based on data, as well as the ability to process more than 5 petabytes of data yearly. The IT systems of the company are of utmost importance in upholding production precision, as seen by a product defect rate continuously below 1 in 10,000 units. Additionally, these systems are crucial in guaranteeing compliance with worldwide pharmaceutical and medical device laws, with an adherence rate of 99%. Furthermore, a substantial portion of the yearly IT budget, around 15% amounting to $1.65 billion, is specifically allocated towards cybersecurity endeavors to protect valuable healthcare information and intellectual assets. These figures highlight Johnson & Johnson's commitment to technical preparedness, quality guarantee, adherence to regulatory standards, and cybersecurity in providing healthcare goods and services of superior quality. Organizational Size, Life Cycle, and Possible Decline 39
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Organization Size Organizational size refers to variables or structures that make up an organization. Different elements may be used to determine the size, such as sales volume, assets value, client portfolio, and amount of floor occupied, among other ways. According to Daft, one reason behind organizational growth is to increase competence in the global market. A common way of achieving organizational growth is using modern technology. Increasing the value of global businesses also contributes to organizational growth. Common multinationals such as Pfizer and Meck have adopted this growth strategy. As a global pharmaceutical dealer, Johnson & Johnson ranked 40 th in the Fortune 500 list of 2023 US corporations. 43 Its fields of operation are pharmaceuticals, consumer products, and medical devices. Sales from each sector are combined to project net returns. The pharmaceutical sector generates the highest sales, with the current statistics at 55% of organizational sales. When the COVID-19 pandemic was spreading in 2021, Johnson and Johnson strengthened its presence by acquiring authorization to utilize its vaccine for emergency purposes. The vaccine received wide approval due to its one-shot prescription and simple storage methods. The trend in sales of its leading pharmaceutical products between 2022 and 2022 is summarized in the table below. Figure 8: Organizational Size 44 In terms of labor, the company has engaged approximately 153,000 workers worldwide 43 Loftus, P. (2019). Johnson & Johnsons legal challenges mount. The Wall Street Journal . 44 Johnson & Johnson( 2023, Aug 31) Johnson & Johnson - Statistics & Facts. Retrieved , from https://www.statista.com/topics/1517/johnson-and-johnson/ 40
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J as of August 2023. The revenue generated in 2022 was $94.94 billion, while 2020 recorded a sales volume of $ 80 billion. The income discovered in 2022 was $ 1.73 billion. Total assets owned by the company were $ 187.4 billion in 2022, and the net income for the period was $17.94 billion. Johnson and Johnson's organization operates in 60 countries, and more than 175 nations use the company’s products. A continuous growth in employment rate has been observed in the company over the past few decades. The company has 250 subsidiaries, owning popular brands such as Tylenol, Acuvue contact lenses, and Band-Aid. Due to its large size, it has magnificent manufacturing facilities, modernized research centers, and well-established distribution points. Large outlets enable it to serve a wide customer base worldwide. Figure 9: Johnson & Johnson global sales from 2011 to 2022 45 Life Cycle The organizational life cycle is the steps organizations go through, from the early stages 45 Johnson & Johnson( 2023, Aug 31) Johnson & Johnson - Statistics & Facts. Retrieved , from https://www.statista.com/topics/1517/johnson-and-johnson/ 41
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J of formation to the latter stages of their existence. These stages can be likened to the human life evolution from birth to growth and eventually death. 46 The pattern followed by an organization from birth to its termination defines its life cycle. Daft summarizes the cycle into four stages, with entrepreneurship being the earliest. Entrepreneurial stage Here, companies experience their small beginnings. Few activities occur within the organization and are handled by a few employees. The hierarchy observed is brief, which leads to less time spent on completing processes. At this stage, supervisors have little work to do since the employees fully commit to their roles. Organizational staff fully pledge loyalty to support the brand's performance in the market. Limited leadership can, however, become a challenge if it is not increased with the company's growth. Due to the corporation of employees, much of the energy within the organization is channeled towards developing the product. The management invests time in analyzing the trends in the market, spotting their target audience, and making the brand visible in the marketplace. The company grows with time, and more employees are employed. The stage generally forms the foundation of the organization. Collectivity stage The collective stage forms the second stage of the life cycle. The level comprises a more established organization compared to the later stage. Growth occurs, and its impact begins to be felt. The aims and vision of the organization become clearer. The organization has acquired a market share, and customers have begun identifying with it. More sales happen at this level, pushing the organization to pursue new ventures and introduce new brands. The increased activities create a sense of direction among the employees. 47 They are expected to implement creativity and innovation while executing roles, but within the limits observed by the company. The workers begin to move from communal activities to more specified roles. As internal operations increase, divisions are implemented within the organization. Employees use open and informal communication methods to align with the changes and adapt. Company operations attract more growth, and management needs to increase. A fast rate of growth can overwhelm the management, leading to growth. Several people are required to handle the operations of the company effectively. Departments raise their managers in the interest of boosting productivity. The overall management remains, making their roles easier by coordinating with the lower-level managers. Communications slowly move from depending on informal methods to depending on formal ones. Employees aim to strengthen the brand and increase market share. 46 Barra, E. (2016). Johnson & Johnson. 47 Waldstreicher, J. (2021, June 10). How Johnson & Johnson Made Hard Decisions During Covid. Harvard Business Review. Retrieved from: https://hbr.org/2021/06/how-johnson-johnson-made-hard decisions-during-covid 42
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Formalization stage The formalization stage follows the collectivity stage. Here, most activities are done formally and using a well-established hierarchy. Activities are regulated, and supervision is strong. Management happens in several layers, whereby different sectors have their leadership. Workers are assigned different positions and entrusted with the mandate of developing them. According to Dart, communications between the various groups are facilitated by group heads. More growth increases division within the company. 48 The relationship between middle-level managers and upper managers decreases as each focuses on different expectations. The middle ones focus on organizational activities, while the upper ones look for ways to uphold the entire organization. Due to the many leaders present, implementing innovation becomes complex. At this point, the divisions that were initially created to boost organizational activities turn out to be a hindrance to progress. Activities that consumed less time previously now have to go through a series of steps before receiving approval. Much time is wasted in the process, and often, some information gets distorted. The formalization stage seeks to establish better ways of performing duties while maximizing profits. The organization also aims at diversifying and launching new product lines. Elaboration stage The final stage is elaboration, which Daft describes as an action or death. Challenges that threaten sustainability arise. Some common causes of these threats are high competition and diseconomies of scale. The compulsory thing for survival is change. If no innovation is implemented at this level, the company risks death. Consequences of mishandling this stage include lower revenues, decreased customer loyalty, and less market share. The need for aligning operations and minimizing challenges forces management to increase the freedom of emerging departments. Management is, therefore, spread from the upper leader to the middle and low-level managers. Decision-making now falls in the arms of more individuals. 49 These changes are implemented through the implementation of new systems of governance within the organization. The organizational leadership leaves the company at this point. For an organization to exist and grow, it has to pass through the highlighted stages. The strategies used to achieve success in the first stage have been associated with competencies as companies grow. Daft precisely puts it that achieving success during an organization's fifth year is independent of the initiatives that achieved success in the first year. Undergoing the life cycle stages may cause rapid growth in a company or decline. 48 Galuszka, P. (2018, July 2). Johnson & Johnson CEO: Decentralization Works. Cbsnews.com. https://www.cbsnews.com/news/johnson-amp-johnson-ceo-decentralization works/ 49 Knowledge at Wharton Staff. (2018, June 18). Johnson & Johnson CEO William Weldon: Leadership in a Decentralized Company. Knowledge at Wharton. Retrieved from: https://knowledge.wharton.upenn.edu/podcast/knowledge-at-wharton-podcast/johnson- johnson ceo-william-weldon- leadership-in-a-decentralized-company/ 43
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Possible Decline The inherent cyclicality of the corporate environment implies that even the most formidable firms are susceptible to challenges and potential downfall. The phenomenon of numerous individuals achieving success has been widely acknowledged, and in a similar vein, the realm of business literature is replete with accounts of formerly dominant corporations that experienced setbacks and difficulties or even ceased to exist. In order to maintain its position as a worldwide leader, Johnson & Johnson must employ a strategic combination of innovation, adaptation, and vigilance to mitigate several possible challenges. The healthcare landscape is subject to ongoing external changes. Global health crises, such as pandemics or epidemics, have the potential to disrupt meticulously crafted plans. The regulatory landscapes, particularly within the healthcare industry, are subject to constant change and development. The inclination towards more stringent laws, both at the national and global levels, can influence the initiation of product releases, marketing strategies, and sales outcomes. In addition, the extensive worldwide presence of the corporation renders it vulnerable to geopolitical conflicts and trade restrictions. Johnson & Johnson's public perception and level of trust have undergone significant scrutiny due to several legal and public relations obstacles. The firm has faced substantial legal costs of nearly $3.9 billion in 2020 due to legal claims related to its talc-based products and specific medical device concerns. These allegations have also harmed the company's brand, potentially undermining consumer confidence. If these setbacks are not proactively addressed, they can lead to the gradual deterioration of a brand over an extended period. As Johnson & Johnson undergoes internal expansion and diversification, there is a potential for the emergence of risks such as isolated operations, misunderstanding, and a lack of alignment with the overarching company goal. The hindrance of growth and innovation can occur due to managerial misjudgments, lack of anticipation of market shifts, or excessive risk aversion. The dangers associated with complacency, in which prior accomplishments foster an erroneous perception of safety, can be particularly deceptive. A conglomerate of Johnson & Johnson's magnitude must prioritize maintaining internal processes that exhibit the same agility and responsiveness as those found in significantly smaller businesses. Notwithstanding these potential hurdles, its extensive and enduring history shows Johnson & Johnson's tenacity and adaptability. One of the company's primary advantages is its varied business model, which enables the distribution of risks across many sectors. The company's significant allocation of funds towards research and development, surpassing $12 billion in the year 2021, highlights its dedication to innovative advancements, maintaining a competitive edge, and tackling emerging health issues. 50 Given the dynamic global demographic, developing healthcare requirements, rapid technological progress, and unpredictable worldwide occurrences, the organization must cultivate a culture that promotes ongoing learning, flexibility, and innovation. By adopting this 50 Knight, R. (2022, June 21). Johnson & Johnson’s head of performance management shares how the company revamped its review system to be more compassionate and conversational. Business Insider. Retrieved from: https://www.businessinsider.com/johnson-and-johnson-changed- performance-review-process-during-pandemic 44
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J approach, Johnson & Johnson can effectively safeguard its reputation and sustain its market leadership position in the unpredictable future dynamics. Organizational Culture Organizational culture highly impacts the decisions made within a business. The process of conducting an internal strategic management audit should, therefore, feature the culture adopted. It is in the company culture where strengths such as ethical beliefs and work ethics are built. Culture outlines the values and principles that a company stands for. These guidelines shape behavioral aspects and decision-making processes. The elements contained in organizational culture are affected by factors such as employees, the nature of work, the target audience, and the leadership. The culture of Johnson and Johnson is enclosed in a decentralized administration system. The multinational is first subdivided into independent sectors for easy monitoring and supervision. Values embraced by the multinational are traced back to the company's hero and pioneer, Robert Wood Johnson. Their main slogan affirms that Johnson and Johnson owes the doctors, patients, and nurses a priority aid to cement the company culture. Above all, the company emphasizes its value and equal treatment for all humanity. They believe in using present-day technology to impart lives and cause revolutions in the medical sector. The Credo emphasizes the company's respect for people, development, and communication. The company staff are required to undergo training on the formal statement to pass on the real meaning of the company to stakeholders. Johnson and Johnson identifies several attributes that define the conduct of its employees and leaders. The first element is integrity. All employees are expected to behave transparently. Every action taken within and for the company should be transparent and with clear intentions. The company emphasizes honest practices, which also uphold ethics. High degrees of teamwork are expected from employees. Individuals must respect and value their colleagues and collaborate to achieve a common goal. The company's mantra is that diverse opinions and perspectives lead to better decision-making processes. Everyone is, therefore, encouraged to speak their mind concerning the various issues affecting the company. Innovation is key for all company employees. 51 The company believes modern technology has great potential to transform the health sector. Employees should strive to invent new ways of performing their roles. As healthcare needs evolve with changing times, the company believes that an innovative workforce can contribute to maintaining company relevance by providing timely services. Therefore, an entrepreneurial attitude helps solve the numerous unsolved healthcare needs. The value of inclusion and inclusion in the company is weighty. They train their teams to respect and appreciate persons from all walks of life, regardless of their differences. The value of innovation 51 Oprysko, C. (2023, August 14). Johnson & Johnson spinoff adds first lobbyists. POLITICO. Retrieved from: https://www.politico.com/newsletters/politico-influence/2023/08/14/johnson-johnson- spinoff-adds-first-lobbyists- 00111143 45
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J is boosted through embracing innovation. The inclusion factor has led to the reforms of, for example, gender identity. Persons who identify with another gender beyond the traditional absolutes of male and female are appreciated. Acceptance is key, especially for millennials and Generation Z. The company also maintains a culture where actors must act with care and concern for consumers. The care is further spread to all stakeholders. Right from its employees, Johnson and Johnson endeavors to ensure that everyone feels loved and appreciated. Their clients and communities are also treated carefully 52 . The principle serves to reduce the possible harm that may occur in the process of providing healthcare help. When employees act out of love, the chances of exposing toxic products to the public are low. The need to adhere to ethical requirements also provides boundaries to the actions of these employees. Quality services are therefore produced. The cultural organization of the company ensures that efforts are pooled together to build a conducive environment for all. Johnson and Johnson improve community well-being by creating an environment where humanity is considered equal with no superior or inferior actors. The working environment is guided by the notion that each perspective is important for achieving general good. Leaders gain a compass for their decision-making processes from the culture. An emphasis on innovation compels workers to seek personal development constantly, and in the process, high-quality goods and services are created. The company recognizes that its employees' diverse perspectives, backgrounds, and experiences are invaluable assets. The company encourages employees to work together across disciplines to solve complex healthcare challenges and drive innovation by fostering an inclusive workplace. The company's culture strongly emphasizes serving patients and meeting their evolving healthcare needs. The Johnson & Johnson company is dedicated to understanding the patient journey and developing innovative solutions that enhance the quality of care and improve the well-being of individuals worldwide. This objective is guided by their efforts in research and innovation as their fundamental aspect of the culture at Johnson & Johnson. Employees are encouraged to think creatively, take calculated risks, and seek new ways to advance healthcare. This innovation encompasses more than the invention of new products but also innovative approaches to processes, technology, and business models. The Johnson & Johnson culture significantly emphasizes ethical behavior and regulatory compliance within and beyond the organization. The organization implements stringent internal controls, rules, and training initiatives to guarantee that its staff adhere to ethical and legal principles. Johnson & Johnson demonstrates a robust dedication to social responsibility and community engagement. The corporation actively participates in humanitarian undertakings, adopts sustainable business practices, and supports global health programs, showcasing its commitment to generating a 52 Lipsky, D. B. (2015). The Future of Conflict Management Systems. Conflict Resolution Quarterly. Retrieved from: https://doi.org/10.1002/crq.21133 46
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J beneficial influence beyond its primary commercial operations. This observation demonstrates that the organizational culture of Johnson & Johnson is a manifestation of its deeply ingrained beliefs and the enduring principles articulated in its value system. These values emphasize ethics, teamwork, patient-centered care, innovation, employee well-being, and social responsibility. The cultural aspects within the organization have played a pivotal role in facilitating the company's enduring achievements and its adeptness in managing the intricacies inherent in the healthcare sector. Johnson & Johnson distinguishes itself as an organization that demonstrates dedication towards its employees, patients, customers, and the wider global community, following its overarching objective of enhancing global health and well-being. Ethical Values As a multinational company, Johnson and Johnson observes a well-structured ethical routine known as Credo. The organization commits to strict adherence to sustainable and responsible marketplace actions. They achieve this through regularly carrying out staff training outlining organizational policies and procedures for executing sensitive activities. Every subsidiary company observes compliance oversight through the support of top management. A special team of Johnson and Johnson Healthcare Compliance Officers(HCCOs) enacts the compliance of industry ethics. These HCCOs directly communicate with the top organizational director, company law department, GA & A officers, and the company's Chief Compliance Officer. The company's ethical standards include integrity, corporate social responsibility, legal research, ethical innovation, inclusivity, and diversity. Johnson and Johnson observe corporate Social responsibility through participating in community programs. They hold frequent community events whereby community members are enlightened about health challenges and ways of keeping safe. The company also partners with other organizations to solve stubborn societal challenges. Johnson and Johnson also delights in providing the public with high-quality, effective health products. The potential of the company's products to save lives and improve people's health standards is notable. While providing these solutions, Johnson and Johnson ensures that the environment's well-being is not left behind. The company's implementation of Environmental, Social, and Government (ESG) programs brings healthcare closer to the common citizen. The company's efforts to build a healthy planet have changed many people's lives. The ethics contained in the company credo serve other purposes beyond providing behavioral guidance. The management and employees view the requirements as part of the ingredients of progress. 53 Due to the sensitivity attached to being a player in the health industry, the company operates within the confines of the law. The environmental concern can be proved by a report by Working Mother Magazine, which featured Johnson and Johnson among the leading green companies for babies in 2010. In making medical explorations, the company has a 53 Johnson & Johnson. (2023). Our Credo Johnson &Johnson. Retrieved from: https://www.jnjcanada.com/about-us#:~:text=We %20must%20be%20good%20citizens,responsibility%20is%20to%20our%20stockholders. 47
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J record of sticking to strict rules and regulations. They stick to focus on the patient when making new inventions. Their consistency in providing genuine solutions, such as in the case of the COVID-19 pandemic vaccine, has achieved high trust and confidence for the brand. The company is also committed to inclusivity, and diversity is seen in its diverse workforce and regional engagements. The practices of the company are not done in the dark. Not only does healthcare company reveal relevant information concerning products using clear labels, but also holds frequent programs to enlighten the public about new products in the market. While executing these regulations, high degrees of transparency and honesty are maintained. Johnson and Johnson has its fair share of shortcomings. Despite its commitment to act responsibly while offering healthcare solutions, harmful substances have occasionally been found in its products. For example, a case was raised against the company's shampoo product in 2011. Some consumers had identified harmful cancerous chemicals in the brand, a claim upheld by the courts. Legal investigations into the incident affirmed the presence of methylene chloride, a substance whose consumption is prohibited for cosmetic usage by the Food and Drug Administration. Similar cases of including harmful substances in the company's products have often risen. Another gap can be observed in some misleading utterances that were advanced by the company management in 2011. The stakeholders reported acting tastefully by providing investors with false information. Consequences of the malpractice were felt by a famous over- the-counter drug ( Motrin), which was widely recalled. Innovation and Change Innovation Johnson and Johnson has been associated with numerous accounts of successful innovations within the health industry. The impact of its Research and development center can be proved using the new solutions advanced to solve stubborn health challenges. A remarkable example of how the company’s innovation has impacted the world is the discovery of the Johnson &Johnson COVID-19 vaccine in 2021. The company acted swiftly at a time when the world needed the product. The Food and Drug Administration approved its quality, and it was circulated to all parts of the world. The vaccine continues to be used for safeguarding against the pandemic to date. The product is praised by many experts as the best innovation for that year. In 2022, the company recently invented a way of embedding modern tags on medical device bar codes. The Unique Device Identifiers were put on more than 70,000 medical equipment within the US. Health practitioners can obtain crucial details about the gadgets by scanning the code. In 2012, Johnson and Johnson invented a cure for Tuberculosis. The FDA approved the advancement as the first impactful TB drug in 40 years. World Health Organization later recommended drug usage among patients with multidrug-resistant Tuberculosis. The inclusivity aspect of the company was proved by the approval of the cure to be 48
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J used by not only adults but also children above five years. Johnson and Johnson is also associated with discovering the cure for coronary artery disease. The invention minimized risks associated with keeping pulmonaries closed during balloon angioplasty processes. The discovery of an antipsychotic therapy for mental health patients is another fruit of Johnson and John's inventions. The efficiency of the drug was in its self-administration system in the remote setting. Mental health drug invention came as a game changer in treating Schizophrenia. The invention effectively solved the congestion problem at mental health facilities. Patients with mental health conditions continue to benefit from the drug. An interesting innovation by Johnson and Johnson was advanced in 1987 in disposable contact lenses. These devices came with a strong impact on the eye care department. Their realistic validity duration of up to a week achieved high customer satisfaction. The company's contribution to sterilizing medical products can also not be overlooked. The introduction of industrial steam sterilization is a safer and simpler way of disinfecting surgical tools. Other basic innovations advanced by Johnson and Johnson include modern first aid kits, Listerine, Imodium, and brand adhesive bandages. Change The company handled the recent changes bestowed upon the world by the COVID-19 pandemic. Rather than joining most companies in slowing down operations, Johnson and Johnson stepped up its operation gear and ended up with a reliable vaccine. Good management of change is also observable in its values and culture. When the company was in the early stages of its life cycle, gender requirement was limited to males and females. However, a new generation of millennials and Gen Z has risen, with the visible difference in their perspective of gender. In response to this change, the company has clarified its inclusion and diversity value to embrace persons from any gender and racial orientation. Embracing modern data technology has greatly contributed to the success of its endless innovations. Flexibility to conduct business online has increased its presence in the global market. Unlike the traditional physical methods of transactions, Johnson and Johnson utilizes digital platforms to share relevant information with its target audience. Utilizing the Internet for business, inventing vaccines during emergencies, and updating inclusivity terms are symbols of proper change management. Decision-Making Johnson & Johnson, as a prominent figure in the medical industry, emphasizes the utmost significance of making decisions based on facts. At the core of its decision-making mechanism is a complex system that collects data from many sources, including competitors, media outlets, marketplaces, and healthcare facilities. These data undergo rigorous processing using modern systems, providing complete reports for managerial interpretation. Adopting this rigorous methodology is not merely a matter of formality but rather serves to optimize production processes, enhance supply plans, and maintain a consistent and enduring demand. An exemplary 49
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J demonstration of this methodology was observed during the global outbreak of the COVID-19 pandemic. In response to the increasing demand for certain antiviral medications, J&J did not expeditiously expand its production capacity. In contrast, the analysis was conducted systematically, thoroughly examining worldwide demand trends. Additionally, other specialists were engaged to assess the drug's effectiveness in combating COVID-19. Based on this comprehensive evaluation, a judicious determination was reached to augment production levels moderately. The prudent strategy emphasized here highlights the crucial significance of data within J&J's decision-making framework, showcasing the company's dedication to caution and adaptability in the market. The intricate nature of J&J's operations, encompassing a wide range of medical domains such as chronic disease care and HIV/AIDS control, requires a decentralized approach to decision-making. J&J acknowledges the distinctive characteristics of various locations and grants authority to its regional teams to customize decisions that align with specific healthcare needs and environmental factors in each locality. Nevertheless, this decentralization is not without control. Critical choices permeate the organizational structure, facilitating alignment with key organizational units such as finance, production, and operations. This organizational framework not only reinforces J&J's fundamental principles of ethical conduct and active involvement in the community but also guarantees that choices are aligned with the specific requirements of the local context. Within this decentralized paradigm, rigorous protocols aim to analyze decisions regarding their impact on stakeholders, alignment with the company's ethical values, and adherence to global healthcare standards. In conjunction with its decentralized organizational framework, J&J acknowledges situations in which top-down decision-making is crucial. The upper echelons of J&J are responsible for making decisions about mergers, significant acquisitions, financial strategy, and expansive market activities. Careful supervision is crucial in making high-stakes decisions since it guarantees conformity with J&J's broad corporate strategy. However, inside these centralized decision-making structures, there is a symbiotic relationship with dispersed teams, which exemplifies J&J's dedication to comprehensive and inclusive decision-making processes. The decision-making philosophy of J&J is rooted in two fundamental principles: a dedication to social responsibility and a steadfast adherence to an ethical framework. Each choice undergoes a thorough evaluation to assess its influence on society to achieve beneficial outcomes for consumers, partners, and shareholders. J&J prioritizes societal well-being over mere revenue, particularly in crises, as guided by their guiding principles. This idea is further supported by a comprehensive ethical framework prioritizing collaboration, transparency, and evidence-based decision-making. Johnson & Johnson's unrelenting dedication to ethical, safe, and internationally resonant judgments is evident through their collaborative efforts with external organizations, strict adherence to rigorous randomized studies, and alignment with regulatory authorities such as the FDA. Conflict, Power, and Politics 50
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Conflict Conflict arises as an inherent consequence of intricate organizational frameworks and multifaceted activities, and in the case of Johnson & Johnson (J&J), a large-scale corporation, it is a prevailing actuality that emerges in various forms. Johnson & Johnson (J&J) is positioned at the intersection of many viewpoints, business approaches, and stakeholder concerns due to its extensive worldwide presence, operations in various geopolitical contexts, and management of numerous product categories. Throughout its history, Johnson & Johnson has experienced a range of conflicts. The decentralized structure of the corporation has been both a catalyst for departmental disputes and a facilitator of flexibility and adaptability. Disagreements can arise from budget allocations, project prioritizations, or interpretations of the company's core principles. The conflicts may arise due to disparities in the cultural backgrounds of personnel, divergent regional market demands, or conflicting views among different levels of leadership. J&J's prominent market position has been subjected to extensive scrutiny and competition from external entities. Conflicts fueled by competition, frequently centered on market shares, intellectual property, and product advances, have been prevalent. Regulatory conflicts have also arisen, as Johnson & Johnson, similar to several prominent pharmaceutical companies, operates within a dynamic environment characterized by evolving medical protocols, rigorous drug authorization processes, and severe adherence to safety regulations. The legal disputes surrounding the company's talc-based goods posed legal obstacles and a risk to its brand, as its public image was jeopardized. However, the narrative around J&J does not solely revolve around encountering issues; rather, it centers on efficiently resolving them. The organization's resilience is attributed to its systematic approach to resolving conflicts. Johnson & Johnson (J&J) has always prioritized establishing a corporate environment that fosters open communication, where individuals are encouraged to express their differing opinions, which are acknowledged and dealt with transparently. The company's credo prioritizes the needs and well-being of patients and consumers, serving as a guiding principle throughout challenging periods. This ensures that actions are consistent with the company's fundamental ethical values. Johnson & Johnson's dedication to collaborative problem-solving has frequently resulted in converting disagreements into catalysts, propelling the corporation towards inventive resolutions, promoting knowledge exchange within the organization, and facilitating individual and collective development. J&J's conflict response exemplifies its overarching organizational philosophy of confronting issues directly, adapting to them, and ultimately emerging with increased strength. Power and Politics Power dynamics and politics are inherently complex and tremendously important in a multilayered company like Johnson & Johnson (J&J). The manifestation of power inside J&J is seen in its hierarchical frameworks and within the wider context of its stance within the industry. J&J's significant influence in the healthcare industry on a global scale can be attributed to its 51
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J exceptional research infrastructure, substantial financial resources, and extensive market presence. The dominant position of J&J in the sector provides the company with the ability to influence and shape healthcare paradigms, establish strong partnerships, participate in significant negotiations, and lead important health campaigns on a global scale. However, it is important to acknowledge that the influence of J&J is closely tied to a fundamental responsibility for ethical leadership, which guarantees that its power contributes to beneficial societal outcomes and maintains its longstanding principles. Upon further examination of the organization's internal structure, the complexities of power dynamics grow increasingly sophisticated. Hierarchies, departments, and cross-functional teams frequently engage in a nuanced interplay of influence and persuasion to imprint their visions on the strategic trajectory of the organization and attain an optimal allocation of resources. The decentralized model employed by J&J introduces additional complexities to these interactions. While this organizational framework provides regional and functional bodies with authority and flexibility, it also requires constant power adjustment to maintain local significance and consistency with the organization's overall goals. In contexts where power experiences fluctuations, the presence of politics is frequently observed. Like many other large organizations, Johnson & Johnson's extensive scope is not immune to internal political dynamics. Political stratagems can arise due to ambitions, competition for prominence, and the pursuit of supremacy. However, a notable characteristic of J&J is its fundamental dedication to its core beliefs and ethical principles. J&J endeavors to cultivate an environment characterized by openness, open communication, and a collaborative culture to mitigate the influence of political undercurrents and safeguard the integrity of its core mission. Key Findings and Recommendations Key Findings The extensive worldwide reach of Johnson & Johnson is a fundamental advantage that greatly enhances its importance within the healthcare sector. The company has achieved a widespread global presence in over 60 countries. The enormous global presence of J&J enables the company to efficiently cater to a wide range of markets and communities across the globe. It facilitates the organization's ability to respond to regional healthcare demands, exploit local prospects, and tackle distinct obstacles in different global regions. One of the primary strengths of Johnson & Johnson lies in its ability to generate money from several sources since it operates within three main segments: pharmaceuticals, consumer health, and medical devices. The act of diversifying one's investments serves to reduce the potential hazards that may arise from over- reliance on a singular sector. As a result, if a particular segment encounters market volatility or difficulties, the company can mitigate possible losses by leveraging the stability and development observed in other sectors. The presence of diversity within J&J enables the 52
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J company to provide a wide array of healthcare solutions and effectively address a diverse range of healthcare needs. The success of Johnson & Johnson can be attributed to its unwavering dedication to innovation, as demonstrated by its significant allocation of resources towards research and development (R&D). In 2021, the corporation demonstrated its commitment to remaining at the forefront of healthcare breakthroughs by allocating over $12 billion towards research and development (R&D). This dedication leads to a strong flow of inventive products, medicines, and technology. The statement solidifies the organization's standing in the industry for providing innovative healthcare solutions that benefit patients' well-being and effectively tackle significant global health issues. The practice of ethical decision-making holds a fundamental position within the corporate culture of Johnson & Johnson, as exemplified by its widely recognized credo. The company's decision-making procedures prioritize social responsibility and patient welfare due to its strong dedication to ethical ideals. Johnson & Johnson continually ensures that its actions follow established worldwide healthcare standards and prioritize safeguarding the well-being of patients and consumers. The ethical compass is a guiding principle for the organization in navigating intricate circumstances and cultivating trust among stakeholders, such as healthcare professionals, regulatory entities, and the general public. Johnson & Johnson's decentralized approach to decision-making grants authority and autonomy to regional and functional units within the organizational structure. The decentralization process allows for increased adaptability and relevance at the local level, enabling prompt and effective answers to various healthcare demands in various geographical areas. By delegating autonomy to its subsidiaries and departments, the corporation may successfully respond to specific market dynamics, regulatory needs, and patient demographics. Recommendations Johnson & Johnson should consider further enhancing its data-driven decision-making processes by investigating the potential integration of advanced data analysis and predictive modeling techniques. This methodology can augment the organization's capacity to forecast market patterns, discern client inclinations, and identify prospective hazards. The utilization of advanced analysis has the potential to provide guidance in the allocation of resources, optimization of marketing tactics, and facilitation of data-driven innovations. It is recommended that the corporation focus on allocating significant resources toward research and development to enhance its innovation pipeline. Engaging in partnerships with nascent technology enterprises and startup ventures will effectively enable J&J to maintain a leading position in the realm of healthcare technology, encompassing domains such as Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT). The technologies can significantly transform patient care and overall healthcare procedures. In light of the disruptions observed in the COVID-19 pandemic, it is recommended that J&J prioritize enhancing supply chain resilience. This involves diversifying sourcing techniques, cooperating closely with suppliers, and researching the incorporation of blockchain technology to promote transparency, traceability, and supply chain robustness. Given the increasing dependence on digital technologies, the 53
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J organization must place a higher emphasis on cybersecurity. Regular upgrades and modifications to cybersecurity policies are important to protect sensitive patient and corporate data. Implementing an agile methodology in cybersecurity will empower J&J to effectively respond to dynamic cyber threats, consequently safeguarding data integrity and upholding patient trust. Johnson & Johnson (J&J) ought to persist and broaden its endeavors in sustainability, including mitigating its environmental impact and adopting ecologically conscious packaging methods. Promoting these sustainability projects within the framework of corporate social responsibility will not only serve to better the company's public perception but also make a meaningful contribution to the overall welfare of society. Due to the healthcare sector's extensively regulated environment, the organization must adopt a proactive stance toward ensuring adherence to regulatory requirements. Maintaining consistent interaction with regulatory entities, proactively anticipating regulatory modifications, and promptly adjusting to new mandates are crucial in guaranteeing adherence and mitigating potential regulatory obstacles. Cultivating a culture that emphasizes ongoing learning and development is vital for cultivating and growing talent inside a business. Efforts to attract, retain, and cultivate highly skilled individuals will maintain Johnson & Johnson's position as a prominent center for innovation and specialized knowledge within the healthcare industry. In light of the inherent unpredictability associated with global health crises, J&J should enhance its crisis management and response strategies. The implementation of cross- functional crisis teams and the regular execution of exercises will augment the organization's preparedness to successfully address unforeseen events, hence safeguarding the uninterrupted provision of patient care and the smooth functioning of business activities. 54
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Bibliography Abubakar, Abubakar Mohammed, Hamzah Elrehail, Maher Ahmad Alatailat, and Alev Elçi. "Knowledge management, decision-making style and organizational performance." Journal of Innovation & Knowledge 4, no. 2 (2019): 104-114. https://www.sciencedirect.com/science/article/pii/S2444569X17300562 Adamovic, M. (2018). An employee-focused human resource management perspective for the management of global virtual teams. The International Journal of Human Resource Management , 29 (14), 2159–2187. https://doi.org/10.1080/09585192.2017.1323227 Alhosnai, K., Kharbanda, K., Almazrouei, H. S., Alzaabi, A. I., Aldhanhani, W., Mostafa, S., ... & Nobanee, H. (2021). Financial analysis of Johnson & Johnson in light of the COVID-19 vaccination research developments. Available at SSRN 3896177 . ARC Advisory. (2020). Johnson & Johnson’s Industrial IoT Strategy for Manufacturing and Predictive Maintenance. https://www.arcweb.com/blog/johnson-johnsons-industrial-iot- strategy-manufacturing-predictive-maintenance Baril, M. B. (2021, February 16). Council Post: The High Costs Of Unmanaged Conflict In Your Organization . Forbes. https://www.forbes.com/sites/forbescoachescouncil/2021/02/16/the-high-costs-of- unmanaged-conflict-in-your-organization/ Barra, E. (2016). Johnson & Johnson. Bartlett, C. A., & Ghoshal, S. (1989). Managing across borders: The transnational solution. Harvard Business School Press. Bocken, Nancy MP, and Thijs HJ Geradts. "Barriers and drivers to sustainable business model innovation: Organization design and dynamic capabilities." Long range planning 53, no. 4 (2020): 101950. https://www.sciencedirect.com/science/article/pii/S0024630119301062 Boland, R. (2018). How J&J uses consumer data to enhance the customer experience. Retrieved from https://mackinstitute.wharton.upenn.edu/2018/consumer-data-robert-boland/ Business Strategy Hub. (2023). Johnson & Johnson Mission Statement| Vision| Core Values| Analysis 2023. Retrieved from: https://bstrategyhub.com/johnson-johnson-mission- statement-vision-core-values-analysis/ Cote, C. (2023, September 7). 5 Strategies for Conflict Resolution in the Workplace . Business Insights Blog. https://online.hbs.edu/blog/post/strategies-for-conflict-resolution-in-the- 55
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J workplace Daft, R. L. (2015). Organization theory and design . Cengage learning. Data Center Solution | Johnson Controls. (n.d.). Retrieved , from https://www.johnsoncontrols.com/buildings/specialty-pages/engineer-design-center/data- center solution Drugdangers. (2023). Johnson & Johnson. Retrieved from https://www.drugdangers.com/manufacturers/johnson-and-johnson/#:~:text=The %20company%20was%20founded%20in,to%20the%20logo%20used%20today/ Eaddy, L. L. (2012). Johnson & Johnson's Recall Debacle. Galuszka, P. (2018, July 2). Johnson & Johnson CEO: Decentralization Works . Cbsnews.com. https://www.cbsnews.com/news/johnson-amp-johnson-ceo-decentralization-works/ IFAC. (2019). Building data science and analysis capabilities in finance and accounting. https://www.ifac.org/knowledge-gateway/preparing-future-ready professionals/discussion/building-data-science-and-analysis-capabilities-finance-and- accounting Jirásek, M., & Bílek, J. (2018). The organizational life cycle: review and future agenda. Quality Innovation Prosperity , 22 (3), 01-18. Johnson & Johnson (2022, July 19). Johnson & Johnson Reports Q2 2022 Results. Retrieved from: https://www.jnj.com/johnson-johnson-reports-q2-2022-results Johnson & Johnson (n.d). Johnson & Johnson (2021). Environmental, Social, and Governance Resources . Content Lab US https://www.jnj.com/esg-resources Johnson & Johnson (n.d). Johnson &Johnson Debuts San Francisco Bay Area R&D Facility. (2022). Retrieved , from https://www.jnj.com/latest-news/johnson-johnson-debuts-r-d- facility-in-san-francisco-bay-area Johnson & Johnson (n.d).Johnson & Johnson. (2022a). Ethical Framework for Decision-Making During the COVID-19 Pandemic . Content Lab US https://www.jnj.com/our- company/ethical-framework-for-decision-making-during-the-covid-19-pandemic Johnson & Johnson MedTech. (n.d.) Retrived from: https://www.jjvision.com/about-us Johnson & Johnson our history.(2023). Reveived from: https://ourstory.jnj.com/our- beginning#experience-our-beginning-ch-1-3 Johnson & Johnson(2023, Aug 31) Johnson & Johnson - Statistics & Facts. Retrieved from https://www.statista.com/topics/1517/johnson-and-johnson/ 56
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J Johnson & Johnson. (2022c). Guide for Resolving Employee Disagreements in North America . https://www.jnj.com/about-jnj/policies-and-positions/guide-for-resolving-employee- disagreements-in-north-america Johnson & Johnson. (2023). Johnson & Johnson -About us. Retrieved from: https://www.jnjcanada.com/about-us Johnson & Johnson. (2023). Johnson & Johnson consumer health. Retrieved from: https://www.jnjcanada.com/explore-our-brands Johnson & Johnson. (2023). Our Credo Johnson &Johnson. Retrieved from: https://www.jnjcanada.com/about-us#:~:text=We%20must%20be%20good %20citizens,responsibility%20is%20to%20our%20stockholders . Johnson & Johnson. (n.d.). Johnson & Johnson: How we are organized. Retrieved from: https://www.jnj.com/sites/default/files/pdf/how- we-are-organized.pdf/ Karim, S., & Mitchell, W. (2004). Innovating through acquisition and internal development: A quarter-century of boundary evolution at Johnson & Johnson. Long Range Planning , 37 (6), 525-547. Knight, R. (2022, June 21). Johnson & Johnson's head of performance management shares how the company revamped its review system to be more compassionate and conversational . Business Insider. https://www.businessinsider.com/johnson-and-johnson-changed- performance-review-process-during-pandemic-2021-5?r=US&IR=T Knowledge at Wharton Staff. (2018, June 18). Johnson & Johnson CEO William Weldon: Leadership in a Decentralized Company . Knowledge at Wharton. https://knowledge.wharton.upenn.edu/podcast/knowledge-at-wharton-podcast/johnson johnson-ceo-william-weldon-leadership-in-a-decentralized-company/ LaFraniere, S., Weiland, N., & Stolberg, S. G. (2021, June 11). The FDA tells Johnson & Johnson that about 60 million doses made at a troubled plant cannot be used. The New York Times . https://www.nytimes.com/2021/06/11/us/politics/johnson-covid-vaccine emergent.html Lindsley, Craig W. "New 2017 data and statistics for pharmaceutical products." ACS Chemical Neuroscience 9, no. 7 (2018): 1518-1519. https://pubs.acs.org/doi/full/10.1021/acschemneuro.8b00320 Lipsky, D. B. (2015). The Future of Conflict Management Systems. Conflict Resolution Quarterly , 33 (S1), S27–S34. https://doi.org/10.1002/crq.21133 Liu, Z. (2023). The Financial Statement Analysis of Johnson and Johnson. Highlights in Business, Economics and Management , 10 , 149-154. Loftus, P. (2019). Johnson & Johnsons legal challenges mount. The Wall Street Journal . Oprysko, C. (2023, August 14). Johnson & Johnson spinoff adds first lobbyists . POLITICO. 57
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
ORGANIZATIONAL ANALYSIS OF J&J https://www.politico.com/newsletters/politico-influence/2023/08/14/johnson-johnson- spinoff-adds-first-lobbyists-00111143 Patel, Rikin, Mohamad Kaki, Venkat S. Potluri, Payal Kahar, and Deepesh Khanna. "A comprehensive review of SARS-CoV-2 vaccines: Pfizer, moderna & Johnson & Johnson." Human vaccines & immunotherapeutics 18, no. 1 (2022): 2002083. https://www.tandfonline.com/doi/full/10.1080/21645515.2021.2002083 Saeed, T., Almas, S., Anis-ul-Haq, M., & Niazi, G. (2014). Leadership styles: Relationship with conflict management styles. International Journal of Conflict Management , 25 (3), 214– 225. https://doi.org/10.1108/ijcma-12-2012-0091 Schuhmacher, A., Wilisch, L., Kuss, M., Kandelbauer, A., Hinder, M., & Gassmann, O. (2021). R&D efficiency of leading pharmaceutical companies–A 20-year analysis. Drug discovery today , 26 (8), 1784-1789. Soto, F. (2022, October 27). Johnson & Johnson: Attractive opportunity during market turmoil. Seeking Alpha . https://seekingalpha.com/article/4550014-johnson-and-johnson-attractive- opportunity-during-market-turmoil Statistica. Johnson & Johnson's top pharmaceutical products by sales. Retrieved from: https://www.statista.com/statistics/266405/global-revenue-of-johnson-und-johnsons- pharmaceutical-segment-by-product/ Waldstreicher, J. (2021, June 10). How Johnson & Johnson Made Hard Decisions During Covid . Harvard Business Review. https://hbr.org/2021/06/how-johnson-johnson-made-hard- decisions-during-covid Williams, O. F., & Murphy, P. E. (1990). The ethics of virtue: A moral theory for marketing. Journal of Macromarketing , 10 (1), 19-29. 58
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help